MicroStrategy (MSTR) 10-Q 1 May 24 2024 Q1 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	3 Months Ended
	Mar. 31, 2024	Apr. 24, 2024
Document Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Mar. 31, 2024
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q1
Trading Symbol	MSTR
Entity Registrant Name	MICROSTRATEGY INCORPORATED
Entity Central Index Key	0001050446
Entity Interactive Data Current	Yes
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Title of 12(b) Security	Class A common stock, par value $0.001 per share
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Shell Company	false
Entity File Number	000-24435
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	51-0323571
Entity Address, Address Line One	1850 Towers Crescent Plaza
Entity Address, City or Town	Tysons Corner
Entity Address, State or Province	VA
Entity Address, Postal Zip Code	22182
City Area Code	703
Local Phone Number	848-8600
Document Quarterly Report	true
Document Transition Report	false
Class A
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		15,773,406
Class B Convertible
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		1,964,025

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 81,326	$ 46,817
Restricted cash	2,402	1,856
Accounts receivable, net	115,150	183,815
Prepaid expenses and other current assets	42,714	35,407
Total current assets	241,592	267,895
Digital assets	5,074,152	3,626,476
Property and equipment, net	29,108	28,941
Right-of-use assets	55,093	57,343
Deposits and other assets	31,757	24,300
Deferred tax assets, net	919,837	757,573
Total assets	6,351,539	4,762,528
Current liabilities:
Accounts payable, accrued expenses, and operating lease liabilities	41,866	43,090
Accrued compensation and employee benefits	40,617	50,045
Accrued interest	10,878	1,493
Current portion of long-term debt, net	492	483
Deferred revenue and advance payments	215,955	228,162
Total current liabilities	309,808	323,273
Long-term debt, net	3,558,801	2,182,108
Deferred revenue and advance payments	6,486	8,524
Operating lease liabilities	58,430	61,086
Other long-term liabilities	17,552	22,208
Deferred tax liabilities	357	357
Total liabilities	3,951,434	2,597,556
Commitments and Contingencies
Stockholders' Equity
Preferred stock undesignated, $0.001 par value; 5,000 shares authorized; no shares issued or outstanding	0	0
Additional paid-in capital	4,247,704	3,957,728
Treasury stock, at cost; 8,684 shares and 8,684 shares, respectively	(782,104)	(782,104)
Accumulated other comprehensive loss	(13,169)	(11,444)
Accumulated deficit	(1,052,352)	(999,234)
Total stockholders' equity	2,400,105	2,164,972
Total liabilities and stockholders' equity	6,351,539	4,762,528
Class A
Stockholders' Equity
Common stock	24	24
Class B Convertible
Stockholders' Equity
Common stock	$ 2	$ 2

CONSOLIDATED BALANCE SHEETS (Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Mar. 31, 2024	Dec. 31, 2023
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Treasury stock, shares	8,684,000	8,684,000
Class A
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	330,000,000	330,000,000
Common stock, shares issued	24,367,000	23,588,000
Common stock, shares outstanding	15,683,000	14,904,000
Class B Convertible
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	165,000,000	165,000,000
Common stock, shares issued	1,964,000	1,964,000
Common stock, shares outstanding	1,964,000	1,964,000

CONSOLIDATED STATEMENTS OF OPER

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands		3 Months Ended
		Mar. 31, 2024	Mar. 31, 2023
Revenues:
Total revenues		$ 115,246	$ 121,915
Cost of revenues:
Total cost of revenues		30,015	27,941
Gross profit		85,231	93,974
Operating expenses:
Sales and marketing		33,451	36,106
Research and development		29,183	31,358
General and administrative		34,666	27,906
Digital asset impairment losses		191,633	18,911
Total operating expenses		288,933	114,281
Loss from operations		(203,702)	(20,307)
Interest expense, net		(11,881)	(14,930)
Gain on debt extinguishment		0	44,686
Other income (expense), net		1,696	(1,443)
(Loss) income before income taxes		(213,887)	8,006
Benefit from income taxes		(160,769)	(453,187)
Net (loss) income		$ (53,118)	$ 461,193
Basic (loss) earnings per share (1)	[1]	$ (3.09)	$ 38.97
Weighted average shares outstanding used in computing basic (loss) earnings per share		17,194	11,834
Diluted (loss) earnings per share (1)	[1]	$ (3.09)	$ 31.79
Weighted average shares outstanding used in computing diluted (loss) earnings per share		17,194	14,575
Total product licenses and subscription services
Revenues:
Total revenues		$ 35,904	$ 36,222
Cost of revenues:
Total cost of revenues		9,171	8,390
Product licenses
Revenues:
Total revenues		12,938	17,412
Cost of revenues:
Total cost of revenues		567	534
Subscription services
Revenues:
Total revenues		22,966	18,810
Cost of revenues:
Total cost of revenues		8,604	7,856
Product support
Revenues:
Total revenues		62,685	65,481
Cost of revenues:
Total cost of revenues		8,547	5,768
Other services
Revenues:
Total revenues		16,657	20,212
Cost of revenues:
Total cost of revenues		$ 12,297	$ 13,783
[1] Basic and fully diluted (loss) earnings per share for class A and class B common stock are the same.

CONSOLIDATED STATEMENTS OF COMP

CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Statement of Comprehensive Income [Abstract]
Net (loss) income	$ (53,118)	$ 461,193
Other comprehensive (loss) income, net of applicable taxes:
Foreign currency translation adjustment	(1,725)	738
Total other comprehensive (loss) income	(1,725)	738
Comprehensive (loss) income	$ (54,843)	$ 461,931

CONSOLIDATED STATEMENTS OF STOC

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock Class A	Common Stock Class B Convertible	Additional Paid-in Capital	Treasury Stock	Accumulated Other Comprehensive Loss	Accumulated Deficit
Beginning Balance at Dec. 31, 2022	$ (383,120)	$ 18	$ 2	$ 1,841,120	$ (782,104)	$ (13,801)	$ (1,428,355)
Beginning Balance (in shares) at Dec. 31, 2022		18,269	1,964		(8,684)
Net Income (Loss)	461,193	$ 0	$ 0	0	$ 0	0	461,193
Other comprehensive income (loss)	738	0	0	0	0	738	0
Issuance of class A common stock upon exercise of stock options	6,750	$ 0	$ 0	6,750	$ 0	0	0
Issuance of class A common stock upon exercise of stock options (in shares)		44	0		0
Issuance of class A common stock under employee stock purchase plan	2,380	$ 0	$ 0	2,380	$ 0	0	0
Issuance of class A common stock under employee stock purchase plan, (in shares)		13	0		0
Issuance of class A common stock upon vesting of restricted stock units, net of withholding taxes	(514)	$ 0	$ 0	(514)	$ 0	0	0
Issuance of class A common stock upon vesting of restricted stock units, net of withholding taxes, (in shares)		4	0		0
Issuance of class A common stock under public offerings, net of issuance costs	338,962	$ 2	$ 0	338,960	$ 0	0	0
Issuance of class A common stock under public offerings, net of issuance costs, (in shares)		1,349	0		0
Share-based compensation expense	16,822	$ 0	$ 0	16,822	$ 0	0	0
Ending Balance at Mar. 31, 2023	443,211	$ 20	$ 2	2,205,518	$ (782,104)	(13,063)	(967,162)
Ending Balance (in shares) at Mar. 31, 2023		19,679	1,964		(8,684)
Net Income (Loss)	22,243	$ 0	$ 0	0	$ 0	0	22,243
Other comprehensive income (loss)	(87)	0	0	0	0	(87)	0
Issuance of class A common stock upon exercise of stock options	5,354	$ 0	$ 0	5,354	$ 0	0	0
Issuance of class A common stock upon exercise of stock options (in shares)		39	0		0
Issuance of class A common stock upon vesting of restricted stock units, net of withholding taxes	(242)	$ 0	$ 0	(242)	$ 0	0	0
Issuance of class A common stock upon vesting of restricted stock units, net of withholding taxes, (in shares)		6	0		0
Issuance of class A common stock under public offerings, net of issuance costs	333,494	$ 1	$ 0	333,493	$ 0	0	0
Issuance of class A common stock under public offerings, net of issuance costs, (in shares)		1,079	0		0
Share-based compensation expense	15,145	$ 0	$ 0	15,145	$ 0	0	0
Ending Balance at Jun. 30, 2023	819,118	$ 21	$ 2	2,559,268	$ (782,104)	(13,150)	(944,919)
Ending Balance (in shares) at Jun. 30, 2023		20,803	1,964		(8,684)
Net Income (Loss)	(143,441)	$ 0	$ 0	0	$ 0	0	(143,441)
Other comprehensive income (loss)	(2,205)	0	0	0	0	(2,205)	0
Issuance of class A common stock upon exercise of stock options	2,113	$ 0	$ 0	2,113	0	0	0
Issuance of class A common stock upon exercise of stock options (in shares)		10	0
Issuance of class A common stock under employee stock purchase plan	1,575	$ 0	$ 0	1,575	$ 0	0	0
Issuance of class A common stock under employee stock purchase plan, (in shares)		7	0		0
Issuance of class A common stock upon vesting of restricted stock units, net of withholding taxes	(747)	$ 0	$ 0	(747)	$ 0	0	0
Issuance of class A common stock upon vesting of restricted stock units, net of withholding taxes, (in shares)		4	0
Issuance of class A common stock under public offerings, net of issuance costs	147,218	$ 0	$ 0	147,218	$ 0	0	0
Issuance of class A common stock under public offerings, net of issuance costs, (in shares)		403	0		0
Share-based compensation expense	16,764	$ 0	$ 0	16,764	$ 0	0	0
Ending Balance at Sep. 30, 2023	840,395	$ 21	$ 2	2,726,191	$ (782,104)	(15,355)	(1,088,360)
Ending Balance (in shares) at Sep. 30, 2023		21,227	1,964		(8,684)
Net Income (Loss)	89,126	$ 0	$ 0	0	$ 0	0	89,126
Other comprehensive income (loss)	3,911	0	0	0	0	3,911	0
Issuance of class A common stock upon exercise of stock options	16,302	$ 1	$ 0	16,301	$ 0	0	0
Issuance of class A common stock upon exercise of stock options (in shares)		82	0		0
Issuance of class A common stock upon vesting of restricted stock units, net of withholding taxes	(2,841)	$ 0	$ 0	(2,841)	$ 0	0	0
Issuance of class A common stock upon vesting of restricted stock units, net of withholding taxes, (in shares)		12	0		0
Issuance of class A common stock under public offerings, net of issuance costs	1,200,415	$ 2	$ 0	1,200,413	$ 0	0	0
Issuance of class A common stock under public offerings, net of issuance costs, (in shares)		2,267	0		0
Share-based compensation expense	17,664	$ 0	$ 0	17,664	$ 0	0	0
Ending Balance at Dec. 31, 2023	2,164,972	$ 24	$ 2	3,957,728	$ (782,104)	(11,444)	(999,234)
Ending Balance (in shares) at Dec. 31, 2023		23,588	1,964		(8,684)
Net Income (Loss)	(53,118)	$ 0	$ 0	0	$ 0	0	(53,118)
Other comprehensive income (loss)	(1,725)	0	0	0	0	(1,725)	0
Issuance of class A common stock upon exercise of stock options	136,088	$ 0	$ 0	136,088	0	0	0
Issuance of class A common stock upon exercise of stock options (in shares)		573	0
Issuance of class A common stock under employee stock purchase plan	2,071	$ 0	$ 0	2,071	$ 0	0	0
Issuance of class A common stock under employee stock purchase plan, (in shares)		7	0		0
Issuance of class A common stock upon vesting of restricted stock units, net of withholding taxes	(1,273)	$ 0	$ 0	(1,273)	$ 0	0	0
Issuance of class A common stock upon vesting of restricted stock units, net of withholding taxes, (in shares)		4	0		0
Issuance of class A common stock under public offerings, net of issuance costs	137,152	$ 0	$ 0	137,152	$ 0	0	0
Issuance of class A common stock under public offerings, net of issuance costs, (in shares)		195	0		0
Share-based compensation expense	15,938	$ 0	$ 0	15,938	$ 0	0	0
Ending Balance at Mar. 31, 2024	$ 2,400,105	$ 24	$ 2	$ 4,247,704	$ (782,104)	$ (13,169)	$ (1,052,352)
Ending Balance (in shares) at Mar. 31, 2024		24,367	1,964		(8,684)

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Operating activities:
Net (loss) income	$ (53,118)	$ 461,193
Adjustments to reconcile net (loss) income to net cash provided by operating activities:
Depreciation and amortization	3,050	3,431
Reduction in carrying amount of right-of-use assets	2,110	2,124
Credit losses and sales allowances	24	21
Deferred taxes	(161,097)	(460,061)
Release of liabilities for unrecognized tax benefits	(73)	(102)
Share-based compensation expense	17,791	17,555
Digital asset impairment losses	191,633	18,911
Amortization of issuance costs on long-term debt	2,557	2,210
Gain on debt extinguishment	0	(44,686)
Changes in operating assets and liabilities:
Accounts receivable	12,166	10,241
Prepaid expenses and other current assets	(6,260)	423
Deposits and other assets	(5,339)	(6)
Accounts payable and accrued expenses	(2,005)	4,230
Accrued compensation and employee benefits	(13,279)	(16,327)
Accrued interest	9,385	7,539
Deferred revenue and advance payments	41,560	33,352
Operating lease liabilities	(2,896)	(2,594)
Other long-term liabilities	(7,622)	(57)
Net cash provided by operating activities	28,587	37,397
Investing activities:
Purchases of digital assets	(1,639,309)	(179,275)
Purchases of property and equipment	(1,545)	(499)
Net cash used in investing activities	(1,640,854)	(179,774)
Financing activities:
Proceeds from convertible senior notes	1,403,750	0
Repayments of secured term loan	0	(159,900)
Repayments of other long-term secured debt	(133)	(128)
Proceeds from sale of common stock under public offerings	137,765	341,062
Issuance costs paid related to sale of common stock under public offerings	(613)	(2,045)
Proceeds from exercise of stock options	134,874	6,750
Payment of withholding tax on vesting of restricted stock units	(1,243)	(497)
Net cash provided by financing activities	1,648,400	187,622
Effect of foreign exchange rate changes on cash, cash equivalents, and restricted cash	(1,078)	351
Net increase in cash, cash equivalents, and restricted cash	35,055	45,596
Cash, cash equivalents, and restricted cash, beginning of period	48,673	50,868
Cash, cash equivalents, and restricted cash, end of period	83,728	96,464
Convertible Senior Notes
Financing activities:
Issuance costs paid	(28,071)	0
Employee Stock Purchase Plan
Financing activities:
Proceeds from sales under employee stock purchase plan	$ 2,071	$ 2,380

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Dec. 31, 2023	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023
Pay vs Performance Disclosure
Net Income (Loss)	$ (53,118)	$ 89,126	$ (143,441)	$ 22,243	$ 461,193

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Mar. 31, 2024
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

Summary of Significant Accounti

Summary of Significant Accounting Policies	3 Months Ended
	Mar. 31, 2024
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	(1) Summary of Significant Accounting Policies (a) Basis of Presentation The accompanying Consolidated Financial Statements of MicroStrategy Incorporated (“MicroStrategy” or the “Company”) are unaudited. In the opinion of management, all adjustments necessary for a fair statement of financial position and results of operations have been included. All such adjustments are of a normal recurring nature, unless otherwise disclosed. Interim results are not necessarily indicative of results for a full year. The Consolidated Financial Statements and Notes to Consolidated Financial Statements are presented as required by the United States Securities and Exchange Commission (“SEC”) and do not contain certain information included in the Company’s annual financial statements and notes. These financial statements should be read in conjunction with the Company’s audited financial statements and the notes thereto filed with the SEC in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023. There have been no significant changes in the Company’s accounting policies since December 31, 2023. The accompanying Consolidated Financial Statements include the accounts of the Company and its subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation.

Recent Accounting Standards

Recent Accounting Standards	3 Months Ended
	Mar. 31, 2024
Accounting Changes and Error Corrections [Abstract]
Recent Accounting Standards	(2) Recent Accounting Standards Crypto Assets In December 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update No. 2023-08, Intangibles—Goodwill and Other—Crypto Assets (Subtopic 350-60): Accounting for and Disclosure of Crypto Assets (“ASU 2023-08”). ASU 2023-08 requires in-scope crypto assets (including the Company's bitcoin holdings) to be measured at fair value in the statement of financial position, with gains and losses from changes in the fair value of such crypto assets recognized in net income each reporting period. ASU 2023-08 also requires certain interim and annual disclosures for crypto assets within the scope of the standard. The standard is effective for the Company for interim and annual periods beginning January 1, 2025, with a cumulative-effect adjustment to the opening balance of retained earnings as of the beginning of the annual reporting period in which the Company adopts the guidance. Prior periods will not be restated. Early adoption is permitted in any interim or annual period for which an entity's financial statements have not been issued as of the beginning of the annual reporting period. The Company expects the adoption of ASU 2023-08 will have a material impact on its consolidated balance sheets, statements of operations, statements of cash flows and disclosures. Although the Company will continue to initially record its bitcoin purchases at cost, upon adopting ASU 2023-08, any subsequent increases or decreases in fair value will be recognized as incurred in the Company's Consolidated Statements of Operations, and the fair value of the Company’s bitcoin will be reflected within the Company's Consolidated Balance Sheets each reporting period-end. Upon adopting ASU 2023-08, the Company will no longer account for its bitcoin under a cost-less-impairment accounting model. The Company is currently evaluating early adoption of ASU 2023-08 and the potential implications of unrealized fair value gains and losses as they relate to the changing global tax landscape. If the Company were to adopt this guidance during 2024, it estimates that its 2024 beginning retained earnings balance would increase by approximately $ 3.1 billion. Income Taxes In December 2023, the FASB issued Accounting Standards Update No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (“ASU 2023-09”). ASU 2023-09 requires enhanced disclosures surrounding income taxes, particularly related to rate reconciliation and income taxes paid information. In particular, on an annual basis, companies will be required to disclose specific categories in the rate reconciliation and provide additional information for reconciling items that meet a quantitative threshold. Companies will also be required to disclose, on an annual basis, the amount of income taxes paid, disaggregated by federal, state, and foreign taxes, and also disaggregated by individual jurisdictions above a quantitative threshold. The standard is effective for the Company for annual periods beginning January 1, 2025 on a prospective basis, with retrospective application permitted for all prior periods presented. Early adoption is permitted. The Company is currently evaluating the impact of this guidance on its disclosures. Segment Reporting In November 2023, the FASB issued Accounting Standards Update No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures (“ASU 2023-07”). ASU 2023-07 requires enhanced disclosures surrounding reportable segments, particularly (i) significant segment expenses that are regularly provided to the chief operating decision maker ("CODM") and included in the reported measure(s) of a segment's profit and loss and (ii) other segment items that reconcile segment revenue and significant expenses to the reported measure(s) of a segment's profit and loss, both on an annual and interim basis. Companies are also required to provide all annual disclosures currently required under Topic 280 in interim periods, in addition to disclosing the title and position of the CODM and how the CODM uses the reported measure(s) of segment profit and loss in assessing segment performance and allocating resources. The standard is effective for the Company for annual periods beginning January 1, 2024 and for interim periods beginning January 1, 2025, with updates applied retrospectively. Early adoption is permitted. The Company is currently evaluating the impact of this guidance on its disclosures.

Digital Assets

Digital Assets	3 Months Ended
	Mar. 31, 2024
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Digital Assets	(3) Digital Assets The Company accounts for its digital assets, which are comprised solely of bitcoin, as indefinite-lived intangible assets in accordance with Accounting Standards Codification (“ASC”) 350, Intangibles—Goodwill and Other . The Company’s digital assets are initially recorded at cost. Subsequently, they are measured at cost, net of any impairment losses incurred since acquisition. Impairment losses are recognized as “Digital asset impairment losses” in the Company’s Consolidated Statement of Operations in the period in which the impairment occurs. Gains (if any) are not recorded until realized upon sale, at which point they are presented net of any impairment losses in the Company’s Consolidated Statements of Operations. In determining the gain to be recognized upon sale, the Company calculates the difference between the sales price and carrying value of the specific bitcoins sold immediately prior to sale. The following table summarizes the Company’s digital asset holdings (in thousands, except number of bitcoins), as of: March 31, December 31, 2024 2023 Approximate number of bitcoins held 214,278 189,150 Digital assets carrying value $ 5,074,152 $ 3,626,476 Cumulative digital asset impairment losses $ 2,460,646 $ 2,269,013 The carrying value on the Company’s Consolidated Balance Sheet at each period-end represents the lowest fair value (based on Level 1 inputs in the fair value hierarchy) of the bitcoins at any time since their acquisition. Therefore, these fair value measurements were made during the period from their acquisition through March 31, 2024 or December 31, 2023, respectively, and not as of March 31, 2024 or December 31, 2023, respectively. The following table summarizes the Company’s digital asset purchases and digital asset impairment losses (in thousands, except number of bitcoins) for the periods indicated. The Company did no t sell any of its bitcoins during the three months ended March 31, 2024 or 2023, respectively. Three Months Ended March 31, 2024 2023 Approximate number of bitcoins purchased 25,128 7,500 Digital asset purchases $ 1,639,309 $ 179,275 Digital asset impairment losses $ 191,633 $ 18,911 From time to time, the Company may be extended short-term credits from its execution partners to purchase bitcoin in advance of using cash funds in the Company’s trading account. The trade credits are due and payable in cash within days after they are extended. In the first quarter of 2024, certain of the assets of MacroStrategy LLC (“MacroStrategy”), a wholly-owned subsidiary of the Company, including bitcoin, were subject to a first priority security interest and lien in order to secure the repayment of short-term trade credits taken in its name. While trade credits are outstanding, the Company may incur interest fees and be required to maintain minimum balances in its trading and collateral accounts with such execution partners. As of March 31, 2024 , the Company had no outstanding trade credits payable. As of March 31, 2024 and December 31, 2023, respectively, approximately 38,557 and 16,081 of the bitcoins held by the Company, which had carrying values of approximately $ 1.606 billion and $ 263.9 million on the Company’s Consolidated Balance Sheets as of March 31, 2024 and December 31, 2023 , respectively, served as part of the collateral for the Company’s 6.125 % Senior Secured Notes due 2028 (the “2028 Secured Notes”), as further described in Note 5, Long-term Debt , to the Consolidated Financial Statements.

Contract Balances

Contract Balances	3 Months Ended
	Mar. 31, 2024
Contract with Customer, Contract Asset, Contract Liability, and Receivable [Abstract]
Contract Balances	(4) Contract Balances The Company invoices its customers in accordance with billing schedules established in each contract. The Company’s rights to consideration from customers are presented separately in the Company’s Consolidated Balance Sheets depending on whether those rights are conditional or unconditional. The Company presents unconditional rights to consideration from customers within “Accounts receivable, net” in its Consolidated Balance Sheets. All of the Company’s contracts are generally non-cancellable and/or non-refundable, and therefore an unconditional right generally exists when the customer is billed or amounts are billable per the contract. Accounts receivable (in thousands) consisted of the following, as of: March 31, December 31, 2024 2023 Billed and billable $ 117,257 $ 186,884 Less: allowance for credit losses ( 2,107 ) ( 3,069 ) Accounts receivable, net $ 115,150 $ 183,815 Changes in the allowance for credit losses were not material for the three months ended March 31, 2024. Rights to consideration that are subject to a condition other than the passage of time are considered contract assets until they are expected to become unconditional and transfer to accounts receivable. Current contract assets included in “Prepaid expenses and other current assets” in the Consolidated Balance Sheets consisted of $ 1.5 million and $ 1.2 million, as of March 31, 2024 and December 31, 2023 , respectively, related to accrued sales and usage-based royalty revenue and performance obligations or services being rendered in advance of future invoicing associated with multi-year contracts. In royalty-based arrangements, consideration is not billed or billable until the royalty reporting is received, generally in the subsequent quarter, at which time the contract asset transfers to accounts receivable and a true-up adjustment is recorded to revenue. These true-up adjustments are generally not material. Non-current contract assets included in “Deposits and other assets” in the Consolidated Balance Sheets consisted of $ 2.7 million and $ 0.9 million, as of March 31, 2024 and December 31, 2023, respectively, related to performance obligations or services being rendered in advance of future invoicing associated with multi-year contracts. During the three months ended March 31, 2024 and 2023 , there were no significant impairments to the Company’s contract assets, nor were there any significant changes in the timing of the Company’s contract assets being reclassified to accounts receivable. Contract liabilities are amounts received or due from customers in advance of the Company transferring the software or services to the customer. In the case of multi-year service contract arrangements, the Company generally does not invoice more than one year in advance of services and does not record deferred revenue for amounts that have not been invoiced. Revenue is subsequently recognized in the period(s) in which control of the software or services is transferred to the customer. The Company’s contract liabilities are presented as either current or non-current “Deferred revenue and advance payments” in the Consolidated Balance Sheets, depending on whether the software or services are expected to be transferred to the customer within the next year. The Company’s “Accounts receivable, net” and “Deferred revenue and advance payments” balances in the Consolidated Balance Sheets include unpaid amounts related to contracts under which the Company has an enforceable right to invoice the customer for non-cancellable and/or non-refundable software and services. Changes in accounts receivable and changes in deferred revenue and advance payments are presented net of these unpaid amounts in “Operating activities” in the Consolidated Statements of Cash Flows. Deferred revenue and advance payments (in thousands) from customers consisted of the following, as of: March 31, December 31, 2024 2023 Current: Deferred product licenses revenue $ 2,879 $ 3,579 Deferred subscription services revenue 60,280 65,512 Deferred product support revenue 148,078 152,012 Deferred other services revenue 4,718 7,059 Total current deferred revenue and advance payments $ 215,955 $ 228,162 Non-current: Deferred product licenses revenue $ 0 $ 0 Deferred subscription services revenue 1,992 3,097 Deferred product support revenue 4,094 4,984 Deferred other services revenue 400 443 Total non-current deferred revenue and advance payments $ 6,486 $ 8,524 During the three months ended March 31, 2024 , the Company recognized revenues of $ 80.8 million from amounts included in the total deferred revenue and advance payments balances at the beginning of 2024. During the three months ended March 31, 2023 , the Company recognized revenues of $ 80.7 million from amounts included in the total deferred revenue and advance payments balances at the beginning of 2023. For the three months ended March 31, 2024 and 2023, there were no significant changes in the timing of revenue recognition on the Company’s deferred balances. The Company’s remaining performance obligation represents all future revenue under contract and includes deferred revenue and advance payments and billable non-cancelable amounts that will be invoiced and recognized as revenue in future periods. The remaining performance obligation excludes contracts that are billed in arrears, such as certain time and materials contracts. The portions of multi-year contracts that will be invoiced in the future are not presented on the balance sheet within accounts receivable and deferred revenues and are instead included in the following remaining performance obligation disclosure. As of March 31, 2024 , the Company had an aggregate transaction price of $ 338.1 million allocated to the remaining performance obligation related to product support, subscription services, product licenses, and other services contracts. The Company expects to recognize $ 247.5 million within the next 12 months and the remainder thereafter .

Long-term Debt

Long-term Debt	3 Months Ended
	Mar. 31, 2024
Debt Disclosure [Abstract]
Long-term Debt	(5) Long-term Debt The net carrying value of the Company’s long-term debt (in thousands) consisted of the following, as of: March 31, 2024 December 31, 2023 2025 Convertible Notes $ 644,698 $ 643,931 2027 Convertible Notes 1,038,316 1,037,306 2030 Convertible Notes 782,248 0 2031 Convertible Notes 592,368 0 2028 Secured Notes 491,622 491,193 Other long-term secured debt 9,549 9,678 Total $ 3,558,801 $ 2,182,108 Convertible Senior Notes Prior Years Issuances of Convertible Notes In December 2020, the Company issued $ 650.0 million aggregate principal amount of 0.750 % Convertible Senior Notes due 2025 (the “2025 Convertible Notes”) in a private offering. The 2025 Convertible Notes are senior unsecured obligations of the Company and bear interest at a fixed rate of 0.750 % per annum, payable semiannually in arrears on June 15 and December 15 of each year, beginning on June 15, 2021 . Holders of the 2025 Convertible Notes may receive additional interest under specified circumstances as outlined in the indenture relating to the issuance of the 2025 Convertible Notes. The 2025 Convertible Notes will mature on December 15, 2025 , unless earlier converted, redeemed, or repurchased in accordance with their terms. In February 2021, the Company issued $ 1.050 billion aggregate principal amount of 0 % Convertible Senior Notes due 2027 (the “2027 Convertible Notes”) in a private offering. The 2027 Convertible Notes are senior unsecured obligations of the Company and do not bear regular interest. However, holders of the 2027 Convertible Notes may receive special interest under specified circumstances as outlined in the indenture relating to the issuance of the 2027 Convertible Notes. Any special interest is payable semiannually in arrears on February 15 and August 15 of each year, beginning on August 15, 2021 . The 2027 Convertible Notes will mature on February 15, 2027 , unless earlier converted, redeemed, or repurchased in accordance with their terms. The terms of the 2025 Convertible Notes and 2027 Convertible Notes, respectively, are discussed more fully in Note 8, Long-term Debt, to the Consolidated Financial Statements of the Company’s Annual Report on Form 10-K for the year ended December 31, 2023. Current Year Issuances of Convertible Notes In March 2024, the Company issued $ 800.0 million aggregate principal amount of 0.625 % Convertible Senior Notes due 2030 (the “2030 Convertible Notes”) in a private offering. The 2030 Convertible Notes are senior unsecured obligations of the Company and bear interest at a fixed rate of 0.625% per annum, payable semiannually in arrears on March 15 and September 15 of each year, beginning on September 15, 2024 . Holders of the 2030 Convertible Notes may receive additional interest under specified circumstances as outlined in the indenture relating to the issuance of the 2030 Convertible Notes (the “2030 Convertible Notes Indenture”). The 2030 Convertible Notes will mature on March 15, 2030 , unless earlier converted, redeemed, or repurchased in accordance with their terms. The total net proceeds from the 2030 Convertible Notes offering, after deducting initial purchaser discounts and issuance costs, were approximately $ 782.0 million. In March 2024, the Company also issued $ 603.8 million aggregate principal amount of 0.875 % Convertible Senior Notes due 2031 (the “2031 Convertible Notes”) in a private offering. The 2031 Convertible Notes are senior unsecured obligations of the Company and bear interest at a fixed rate of 0.875% per annum, payable semiannually in arrears on March 15 and September 15 of each year, beginning on September 15, 2024 . Holders of the 2031 Convertible Notes may receive additional interest under specified circumstances as outlined in the indenture relating to the issuance of the 2031 Convertible Notes (the “2031 Convertible Notes Indenture”). The 2031 Convertible Notes will mature on March 15, 2031 , unless earlier converted, redeemed, or repurchased in accordance with their terms. The total net proceeds from the 2031 Convertible Notes offering, after deducting initial purchaser discounts and issuance costs, were approximately $ 592.3 million. The 2030 Convertible Notes and 2031 Convertible Notes are convertible into shares of the Company’s class A common stock at initial conversion rates of 0.6677 shares per $ 1,000 principal amount (equivalent to an initial conversion price of approximately $ 1,497.68 per share of class A common stock) for the 2030 Convertible Notes and 0.4297 shares per $ 1,000 principal amount (equivalent to an initial conversion price of approximately $ 2,327.21 per share of class A common stock) for the 2031 Convertible Notes. The conversion rates are subject to customary anti-dilution adjustments. In addition, following certain events that may occur prior to the respective maturity dates or if the Company delivers a notice of redemption, the Company will increase the conversion rate for a holder who elects to convert its 2030 Convertible Notes or 2031 Convertible Notes, respectively, in connection with such corporate event or notice of redemption, as the case may be, in certain circumstances as provided in the 2030 Convertible Notes Indenture or 2031 Convertible Notes Indenture, respectively. Prior to September 15, 2029 and September 15, 2030 for the 2030 Convertible Notes and 2031 Convertible Notes, respectively, the 2030 Convertible Notes and 2031 Convertible Notes are convertible only under the following circumstances: (1) during any calendar quarter commencing after the calendar quarter ending on June 30, 2024 (and only during such calendar quarter), if the last reported sale price of the Company’s class A common stock for at least 20 trading days (whether or not consecutive) during the period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter is greater than or equal to 130 % of the conversion price of the 2030 Convertible Notes or 2031 Convertible Notes, respectively, on each applicable trading day; (2) during the five business day period after any five consecutive trading day period (the “measurement period”) in which the “trading price” (as defined in the 2030 Convertible Notes Indenture or 2031 Convertible Notes Indenture, respectively) per $ 1,000 principal amount of the 2030 Convertible Notes or 2031 Convertible Notes, respectively, for each trading day of the measurement period was less than 98 % of the product of the last reported sale price of the Company’s class A common stock and the applicable conversion rate on each such trading day; (3) if the Company calls any or all of the 2030 Convertible Notes or 2031 Convertible Notes, respectively, for redemption, at any time prior to the close of business on the second scheduled trading day immediately preceding the redemption date; and (4) upon occurrence of specified corporate events as described in the 2030 Convertible Notes Indenture or 2031 Convertible Notes Indenture, respectively . On or after September 15, 2029 or September 15, 2030 for the 2030 Convertible Notes and 2031 Convertible Notes, respectively, until the close of business on the second scheduled trading day immediately preceding the maturity dates of the 2030 Convertible Notes or 2031 Convertible Notes, respectively, holders may convert the 2030 Convertible Notes or 2031 Convertible Notes, respectively, at any time. Upon conversion of the 2030 Convertible Notes or 2031 Convertible Notes, respectively, the Company will pay or deliver, as the case may be, cash, shares of the Company’s class A common stock, or a combination of cash and shares of class A common stock, at the Company’s election. Prior to March 22, 2027 or March 22, 2028 for the 2030 Convertible Notes and 2031 Convertible Notes, respectively, the Company may not redeem the 2030 Convertible Notes or 2031 Convertible Notes, respectively. The Company may redeem for cash all or a portion of the 2030 Convertible Notes or 2031 Convertible Notes, at its option, on or after March 22, 2027 or March 22, 2028 , respectively, if the last reported sale price of the Company’s class A common stock has been at least 130 % of the conversion price of the 2030 Convertible Notes or 2031 Convertible Notes, respectively, then in effect for at least 20 trading days (whether or not consecutive), including the trading day immediately preceding the date on which the Company provides a notice of redemption, during any 30 consecutive trading day period ending on, and including, the trading day immediately preceding the date on which the Company provides notice of redemption. The redemption price will be equal to 100 % of the principal amount of the 2030 Convertible Notes or 2031 Convertible Notes, respectively, to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date. Holders of the 2030 Convertible Notes and 2031 Convertible Notes each have the right to require the Company to repurchase for cash all or any portion of their 2030 Convertible Notes or 2031 Convertible Notes, respectively, on September 15, 2028 at a repurchase price equal to 100 % of the principal amount of the 2030 Convertible Notes or 2031 Convertible Notes, respectively, to be repurchased, plus any accrued and unpaid interest to, but excluding the repurchase date. If the Company undergoes a “fundamental change,” as defined in the 2030 Convertible Notes Indenture or 2031 Convertible Notes Indenture, respectively, prior to maturity, subject to certain conditions, holders may require the Company to repurchase for cash all or any portion of their 2030 Convertible Notes or 2031 Convertible Notes, respectively, at a fundamental change repurchase price equal to 100 % of the principal amount of the 2030 Convertible Notes or 2031 Convertible Notes, respectively, to be repurchased, plus any accrued and unpaid interest to, but excluding, the fundamental change repurchase date. The 2030 Convertible Notes Indenture and 2031 Convertible Notes Indenture contain customary terms and covenants, including that upon certain events of default occurring and continuing, either the Trustee or the holders of at least 25 % in principal amount of the outstanding 2030 Convertible Notes or 2031 Convertible Notes, respectively, may declare 100 % of the principal of, and accrued and unpaid interest, if any, on, all the 2030 Convertible Notes or 2031 Convertible Notes, respectively, to be due and payable. The Company incurred approximately $ 18.0 million and $ 11.5 million in customary offering expenses associated with the 2030 Convertible Notes and 2031 Convertible Notes, respectively (“issuance costs”). The Company accounts for these issuance costs as a reduction to the principal amount of the 2030 Convertible Notes and 2031 Convertible Notes, respectively, and amortizes the issuance costs to interest expense from the respective debt issuance dates through September 15, 2028 (the date upon which holders of each of the 2030 Convertible Notes and 2031 Convertible Notes have noncontingent rights to exercise their respective put option) at an effective interest rate of 1.14 % for the 2030 Convertible Notes and 1.31 % for the 2031 Convertible Notes. Although the 2030 Convertible Notes and 2031 Convertible Notes, respectively, contain embedded conversion features, the Company accounts for the 2030 Convertible Notes and 2031 Convertible Notes, respectively, in their entirety as a liability because the conversion features are indexed to the Company’s class A common stock and meet the criteria for classification in stockholders’ equity and therefore do not qualify for separate derivative accounting. Collective Convertible Notes Disclosures The 2025 Convertible Notes, 2027 Convertible Notes, 2030 Convertible Notes, and 2031 Convertible Notes (collectively, the “Convertible Notes”) are senior unsecured obligations and rank senior in right of payment to any of the Company’s indebtedness that is expressly subordinated in right of payment to the Convertible Notes; equal in right of payment to any of the Company’s unsecured indebtedness that is not so subordinated; effectively junior in right of payment to any of the Company’s secured indebtedness to the extent of the value of the assets securing such indebtedness; and structurally junior to all indebtedness and other liabilities (including trade payables) of the Company’s subsidiaries. There have been no adjustments to the initial conversion rates for any of the Convertible Notes as of March 31, 2024. As of March 31, 2024 , the maximum number of shares into which the Convertible Notes could be potentially converted if the conversion features are triggered are 1,633,190 shares, 733,005 shares, 534,160 shares, and 259,431 shares for the 2025 Convertible Notes, 2027 Convertible Notes, 2030 Convertible Notes, and 2031 Convertible Notes, respectively. The following summarizes which periods, if any, that each of the Convertible Notes were convertible at the option of the holders during the three months ended March 31, 2024 and 2023: Three Months Ended March 31, 2024 2023 2025 Convertible Notes Convertible Not convertible at any time 2027 Convertible Notes Not convertible at any time Not convertible at any time 2030 Convertible Notes Not convertible at any time n/a 2031 Convertible Notes Not convertible at any time n/a During the three months ended March 31, 2024, the Company received from certain holders of the 2025 Convertible Notes requests to convert an immaterial principal amount of the 2025 Convertible Notes, which the Company expects to settle during the quarter ending June 30, 2024, in accordance with the terms and provisions of the indenture governing the 2025 Convertible Notes. The Company did no t settle any conversions of the Convertible Notes during the three months ended March 31, 2024 or 2023. The Convertible Notes may be convertible in future periods if one or more of the conversion conditions is satisfied during future measurement periods. As of March 31, 2024 , the last reported sale price of the Company’s class A common stock for at least 20 trading days during the 30 consecutive trading days ending on, and including, March 31, 2024 was greater than or equal to 130 % of the conversion price of the 2025 Convertible Notes on each applicable trading day. Therefore, the 2025 Convertible Notes are convertible at the option of the holders of the 2025 Convertible Notes during the second quarter of 2024. The Company has no t redeemed any of the Convertible Notes as of March 31, 2024. As of March 31, 2024 and December 31, 2023, the net carrying value of the Convertible Notes was classified as a long-term liability in the “Long-term debt, net” line item in the Company’s Consolidated Balance Sheets. The following is a summary of the Company’s convertible debt instruments as of March 31, 2024 (in thousands): March 31, 2024 Outstanding Unamortized Net Carrying Fair Value Principal Amount Issuance Costs Value Amount Leveling 2025 Convertible Notes $ 650,000 $ ( 5,302 ) $ 644,698 $ 2,847,274 Level 2 2027 Convertible Notes 1,050,000 ( 11,684 ) 1,038,316 1,437,616 Level 2 2030 Convertible Notes 800,000 ( 17,752 ) 782,248 1,064,727 Level 2 2031 Convertible Notes 603,750 ( 11,382 ) 592,368 638,466 Level 2 Total $ 3,103,750 $ ( 46,120 ) $ 3,057,630 $ 5,988,083 The following is a summary of the Company’s convertible debt instruments as of December 31, 2023 (in thousands): December 31, 2023 Outstanding Unamortized Net Carrying Fair Value Principal Amount Issuance Costs Value Amount Leveling 2025 Convertible Notes $ 650,000 $ ( 6,069 ) $ 643,931 $ 1,074,713 Level 2 2027 Convertible Notes 1,050,000 ( 12,694 ) 1,037,306 913,808 Level 2 Total $ 1,700,000 $ ( 18,763 ) $ 1,681,237 $ 1,988,521 The fair value of the Convertible Notes is determined using observable market data other than quoted prices, specifically the last traded price at the end of the reporting period of identical instruments in the over-the-counter market (Level 2). For the three months ended March 31, 2024 and 2023, interest expense related to the Convertible Notes was as follows (in thousands): Three Months Ended March 31, 2024 Three Months Ended March 31, 2023 Contractual Amortization of Contractual Amortization of Interest Expense Issuance Costs Total Interest Expense Issuance Costs Total 2025 Convertible Notes $ 1,219 $ 767 $ 1,986 $ 1,219 $ 757 $ 1,976 2027 Convertible Notes 0 1,010 1,010 0 1,006 1,006 2030 Convertible Notes 319 248 567 0 0 0 2031 Convertible Notes 191 89 280 0 0 0 Total $ 1,729 $ 2,114 $ 3,843 $ 1,219 $ 1,763 $ 2,982 The Company did no t pay any interest related to the Convertible Notes during the three months ended March 31, 2024 and 2023 . The Company has no t paid any additional interest or special interest related to the Convertible Notes to date. Senior Secured Notes On June 14, 2021, the Company issued $ 500.0 million aggregate principal amount of 2028 Secured Notes in a private offering. The 2028 Secured Notes bear interest at a fixed rate of 6.125 % per annum, payable semiannually in arrears on June 15 and December 15 of each year, beginning on December 15, 2021 . The 2028 Secured Notes have a stated maturity date of June 15, 2028 , unless earlier redeemed or repurchased in accordance with their terms and subject to a springing maturity date of September 15, 2025 or November 16, 2026 as discussed further below. The Company has no t redeemed any of the 2028 Secured Notes as of March 31, 2024. The 2028 Secured Notes include a springing maturity feature that will cause the stated maturity date to spring ahead to: (1) September 15, 2025 (the “First Springing Maturity Date”), unless on the First Springing Maturity Date (i) the Company has Liquidity (as defined in the 2028 Secured Notes Indenture) in excess of 130 % of the amount required to pay in full in cash the then outstanding aggregate principal amount of, and accrued interest on, the 2025 Convertible Notes or (ii) less than $ 100,000,000 of the aggregate principal amount of the 2025 Convertible Notes remains outstanding, (2) November 16, 2026 (the “Second Springing Maturity Date”), unless on the Second Springing Maturity Date (i) the Company has Liquidity in excess of 130 % of the amount required to pay in full in cash the then outstanding aggregate principal amount of, and accrued interest on, the 2027 Convertible Notes or (ii) less than $ 100,000,000 of the aggregate principal amount of the 2027 Convertible Notes remains outstanding, or (3) the date (such date, an “FCCR Springing Maturity Date”) that is 91 days prior to the maturity date of any future convertible debt that we may issue that is then outstanding (the “FCCR Convertible Indebtedness”), unless on the FCCR Springing Maturity Date (i) the Company has Liquidity in excess of 130 % of the amount required to pay in full in cash the then outstanding aggregate principal amount of and accrued interest on such FCCR Convertible Indebtedness or (ii) less than $ 100,000,000 of the aggregate principal amount of such FCCR Convertible Indebtedness remains outstanding. “Liquidity” is defined in the 2028 Secured Notes Indenture and includes the Digital Asset Market Value (as defined in the 2028 Secured Notes Indenture) of the bitcoin owned by the Company and its Restricted Subsidiaries (as defined in the 2028 Secured Notes Indenture) immediately prior to the issuance of the 2028 Secured Notes (which are referred to as “Existing Digital Assets”). As of March 31, 2024 , for purposes of calculating Liquidity, the Company and its Restricted Subsidiaries owned approximately 92,079 Existing Digital Assets, all of which were unencumbered. The terms of the 2028 Secured Notes are discussed more fully in Note 8, Long-term Debt, to the Consolidated Financial Statements of the Company’s Annual Report on Form 10-K for the year ended December 31, 2023. The 2028 Secured Notes are governed by an indenture containing certain covenants with which the Company must comply, including covenants with respect to limitations on (i) additional indebtedness, (ii) liens, (iii) certain payments and investments, (iv) the ability to merge or consolidate with another person, or sell or otherwise dispose of substantially all the Company’s assets, and (v) certain transactions with affiliates. The Company was in compliance with its debt covenants as of March 31, 2024. As of March 31, 2024 and December 31, 2023, the net carrying value of the 2028 Secured Notes was classified as a long-term liability in the “Long-term debt, net” line item in the Company’s Consolidated Balance Sheets. The following is a summary of the 2028 Secured Notes as of March 31, 2024 (in thousands): March 31, 2024 Outstanding Unamortized Net Carrying Fair Value Principal Amount Issuance Costs Value Amount Leveling 2028 Secured Notes $ 500,000 $ ( 8,378 ) $ 491,622 $ 483,125 Level 2 The following is a summary of the 2028 Secured Notes as of December 31, 2023 (in thousands): December 31, 2023 Outstanding Unamortized Net Carrying Fair Value Principal Amount Issuance Costs Value Amount Leveling 2028 Secured Notes $ 500,000 $ ( 8,807 ) $ 491,193 $ 485,070 Level 2 The fair value of the 2028 Secured Notes is determined using observable market data other than quoted prices, specifically the last traded price at the end of the reporting period of identical instruments in the over-the-counter market (Level 2). For the three months ended March 31, 2024 and 2023, interest expense related to the 2028 Secured Notes was as follows (in thousands): Three Months Ended March 31, 2024 Three Months Ended March 31, 2023 Contractual Amortization of Contractual Amortization of Interest Expense Issuance Costs Total Interest Expense Issuance Costs Total 2028 Secured Notes $ 7,656 $ 429 $ 8,085 $ 7,656 $ 401 $ 8,057 The Company did no t pay any interest related to the 2028 Secured Notes during the three months ended March 31, 2024 and 2023. Secured Term Loan On March 23, 2022, MacroStrategy entered into a Credit and Security Agreement (the “Credit and Security Agreement”) with Silvergate pursuant to which Silvergate issued the $ 205.0 million 2025 Secured Term Loan to MacroStrategy. The terms of the 2025 Secured Term Loan are discussed more fully in Note 8, Long-term Debt, to the Consolidated Financial Statements of the Company’s Annual Report on Form 10-K for the year ended December 31, 2023. On March 24, 2023, MacroStrategy and Silvergate entered into a Prepayment, Waiver and Payoff to Credit and Security Agreement, pursuant to which MacroStrategy voluntarily prepaid Silvergate approximately $ 161.0 million (the “Payoff Amount”), in full repayment, satisfaction, and discharge of the 2025 Secured Term Loan and all other obligations under the Credit and Security Agreement. Upon Silvergate’s receipt of the Payoff Amount on March 24, 2023, the Credit and Security Agreement was terminated and Silvergate released its security interest in all of MacroStrategy’s assets collateralizing the 2025 Secured Term Loan, including the bitcoin that was serving as collateral. The Payoff Amount consisted of a $ 159.9 million payment to repay the full $ 205.0 million outstanding principal amount of the 2025 Secured Term Loan as of March 24, 2023 and a $ 1.1 million payment for accrued unpaid interest on the 2025 Secured Term Loan as of March 24, 2023. The Company also incurred $ 0.1 million in third party fees in connection with the repayment of the 2025 Secured Term Loan. The net carrying value of the 2025 Secured Term Loan as of March 24, 2023, immediately prior to the loan’s repayment, was $ 204.7 million, which resulted in a $ 44.7 million gain on debt extinguishment recognized in the Company’s Consolidated Statement of Operations in the first quarter of 2023. No interest expense related to the 2025 Secured Term Loan was recognized after the debt was repaid in full during the first quarter of 2023. For the three months ended March 31, 2023, interest expense related to the 2025 Secured Term Loan was as follows (in thousands): Three Months Ended March 31, 2023 Contractual Amortization of Interest Expense Issuance Costs Total 2025 Secured Term Loan $ 3,781 $ 31 $ 3,812 The Company paid a final $ 5.1 million in interest related to the 2025 Secured Term Loan during the first quarter of 2023, $ 1.1 million of which was included in the Payoff Amount. Other long-term secured debt In June 2022, the Company, through a wholly-owned subsidiary, entered into a secured term loan agreement in the amount of $ 11.1 million, bearing interest at an annual rate of 5.2 %, and maturing in June 2027 . The loan is secured by certain non-bitcoin assets of the Company that are not otherwise serving as collateral for any of the Company’s other indebtedness. After monthly payments made under the terms of the agreement, the loan had a net carrying value of $ 10.0 million and $ 10.2 million as of March 31, 2024 and December 31, 2023, respectively, and an outstanding principal balance of $ 10.2 million and $ 10.3 million as of March 31, 2024 and December 31, 2023, respectively. As of March 31, 2024 and December 31, 2023 , $ 0.5 million and $ 0.5 million of the respective net carrying values were short-term and were presented in “Current portion of long-term debt, net” in the Consolidated Balance Sheets. Maturities The following table shows the maturities of the Company’s debt instruments as of March 31, 2024 (in thousands). The principal payments related to the 2028 Secured Notes are included in the table below based on the First Springing Maturity Date of September 15, 2025, as if the springing maturity feature discussed above were triggered. As of March 31, 2024, the Company expects to be able to satisfy the requirements in the 2028 Secured Notes Indenture to avoid triggering the springing maturity feature of the 2028 Secured Notes. The principal payments related to the 2030 Convertible Notes and 2031 Convertible Notes, respectively, are included in the table below as if the holders exercised their right to require the Company to repurchase all of the 2030 Convertible Notes and 2031 Convertible Notes on September 15, 2028. Payments due by period ended March 31, 2025 Convertible Notes 2027 Convertible Notes 2030 Convertible Notes 2031 Convertible Notes 2028 Secured Notes Other long-term secured debt Total 2025 $ 0 $ 0 $ 0 $ 0 $ 0 $ 547 $ 547 2026 650,000 0 0 0 500,000 577 1,150,577 2027 0 1,050,000 0 0 0 608 1,050,608 2028 0 0 0 0 0 8,477 8,477 2029 0 0 800,000 603,750 0 0 1,403,750 Thereafter 0 0 0 0 0 0 0 Total $ 650,000 $ 1,050,000 $ 800,000 $ 603,750 $ 500,000 $ 10,209 $ 3,613,959

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Mar. 31, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	(6) Commitments and Contingencies (a) Commitments From time to time, the Company enters into certain types of contracts that require it to indemnify parties against third-party claims. These contracts primarily relate to agreements under which the Company assumes indemnity obligations for intellectual property infringement, as well as other obligations from time to time depending on arrangements negotiated with customers and other third parties. The conditions of these obligations vary. Thus, the overall maximum amount of the Company’s indemnification obligations cannot be reasonably estimated. Historically, the Company has not been obligated to make significant payments for these obligations and does not currently expect to incur any material obligations in the future. Accordingly, the Company has not recorded an indemnification liability on its Consolidated Balance Sheets as of March 31, 2024 or December 31, 2023. (b) Contingencies Brazil Matter Following an internal review initiated in 2018, the Company believes that its Brazilian subsidiary failed or likely failed to comply with local procurement regulations in conducting business with certain Brazilian government entities. On February 6, 2020, the Company learned that a Brazilian court authorized the Brazilian Federal Police to use certain investigative measures in its investigation into alleged corruption and procurement fraud involving certain government officials, pertaining to a particular transaction. The transaction at issue is part of the basis of the previously reported failure or likely failure of the Company’s Brazilian subsidiary to comply with local procurement regulations. The Company is not aware of any allegations that any former employee or the Company made any payments to Brazilian government officials. The Brazilian Federal Police expanded the investigation to include other possible cases of procurement fraud involving Brazilian government entities. Criminal penalties may be imposed against individuals; however, neither employees of the Company’s Brazilian subsidiary nor the subsidiary itself have been targets of the Federal Police investigation. The Company has also learned that Brazil’s Federal Comptroller General filed an administrative action against the Company’s Brazilian subsidiary with respect to the alleged procurement violations. These matters remain the subject of investigation by Brazilian authorities. The Company is taking measures to attempt to resolve these matters. On January 18, 2023, Brazil’s General Superintendence of the Administrative Council for Economic Defense (“SG/CADE”) launched an administrative proceeding to investigate potentially anticompetitive conduct, naming various individuals and companies as defendants including the Company’s Brazilian subsidiary. The proceeding involves conduct relating to transactions with certain Brazilian public and private entities that is part of the basis of the foregoing failure or likely failure of the Brazilian subsidiary to comply with local procurement regulations. The proceeding was precipitated by the Company’s Brazilian subsidiary’s voluntary disclosure of information to SG/CADE that arose out of the internal review initiated in 2018, and the Company’s Brazilian subsidiary has secured a leniency agreement with SG/CADE. If at the end of the proceeding, CADE’s Tribunal confirms that the leniency agreement obligations have been fulfilled, the Company’s Brazilian subsidiary will receive full immunity from fines. The Company believes that a loss is probable in connection with these Brazilian matters. The Company has estimated a minimum loss of $ 1.2 million in respect of these matters and in prior periods established a reserve equal to such amount. Given the stage of these matters, as of March 31, 2024, the Company remains unable to reasonably estimate a range of loss beyond such minimum loss. The aggregate accrued amount for these matters is included as a component of “Accounts payable, accrued expenses, and operating lease liabilities” in the Consolidated Balance Sheets as of March 31, 2024 and December 31, 2023. The final outcome of these matters may result in a loss that is significantly greater than this accrued amount. Any loss associated with the final outcome of these matters may result in a material impact on the Company’s earnings and financial results for the period in which any such additional liability is accrued. However, the Company believes that any loss associated with the final outcome of these matters will not have a material effect on the Company’s financial position. Daedalus Matter As previously reported, on November 4, 2020, a complaint was filed against the Company in the U.S. District Court for the Eastern District of Virginia by a patent assertion entity called Daedalus Blue, LLC (“Daedalus”). In its complaint, Daedalus alleged that the Company infringed U.S. Patent Nos. 8,341,172 (the “’172 Patent”) and 9,032,076 (the “’076 Patent”) based on specific functionality in the MicroStrategy platform. The ’172 Patent relates to a method for providing aggregate data access in response to a query, whereas the ’076 Patent relates to a role-based access control system. On January 29, 2024, the parties executed a settlement agreement pursuant to which the Company received a fully paid-up license to all patents owned by Daedalus as of January 5, 2024, including the ’172 Patent and the ’076 Patent and filed a stipulation of dismissal with the court on February 27, 2024, which the court entered the same day thereby dismissing the case with prejudice. False Claims Act Matter On August 31, 2022, the District of Columbia (the “District”), through its Office of the Attorney General, filed a civil complaint in the Superior Court of the District of Columbia naming as defendants (i) Michael J. Saylor, the Chairman of the Company’s Board of Directors and the Company’s Executive Chairman, in his personal capacity, and (ii) the Company. The District sought, among other relief, monetary damages under the District’s False Claims Act for the alleged failure of Mr. Saylor to pay personal income taxes to the District over a number of years together with penalties, interest, and treble damages. The complaint alleged that the amount of personal income taxes purportedly involved was more than $ 25 million. The complaint also alleged in the sole claim against the Company that it violated the District’s False Claims Act by conspiring to assist Mr. Saylor’s alleged failure to pay personal income taxes. On October 26, 2022, the Company filed a motion to dismiss the District’s complaint. On February 28, 2023, the court ruled on the motion to dismiss, dismissing the sole claim against the Company as well as a claim against Mr. Saylor alleging that Mr. Saylor violated the District’s False Claims Act. The court did not dismiss claims against Mr. Saylor alleging that Mr. Saylor failed to pay personal income taxes, interest and penalties due. On April 13, 2023, the District, through its Office of the Attorney General, filed a motion to amend its complaint to attempt to restore claims under the False Claims Act against both Mr. Saylor and the Company. On May 10, 2023, the court granted the District’s motion to amend its complaint, reinstating the Company as a defendant in the case. The amended complaint alleges that the Company violated the District’s False Claims Act by making and using false records and statements in the form of false withholding filings with the District Office of Tax and Revenue. The amended complaint also alleges that Mr. Saylor violated the District’s False Claims Act by making and using false records and statements and by causing the Company to make and use false records and statements. On June 7, 2023, Mr. Saylor and the Company filed a motion to dismiss the District’s amended complaint with prejudice. On July 5, 2023, the District filed an opposition to the motion to dismiss made by Mr. Saylor and the Company. On July 19, 2023, Mr. Saylor and the Company filed a reply in support of their motion to dismiss. On July 31, 2023, the court denied Mr. Saylor’s and the Company’s motion to dismiss the amended complaint. On August 22, 2023, the Company and Mr. Saylor filed a motion asking the court to reconsider its July 31 decision or, in the alternative, to certify for interlocutory review two case-dispositive issues relating to the validity of tax-related amendments to the District’s False Claims Act and authority of the Office of the Attorney General to sue for allegedly unpaid taxes. On October 31, 2023, the court denied Mr. Saylor’s and the Company’s motion for reconsideration or, in the alternative, certification for interlocutory review. The final outcome of this matter is not presently determinable. Various Legal Proceedings and Contingent Liabilities The Company is also involved in various legal proceedings arising in the normal course of business. Although the outcomes of these legal proceedings are inherently difficult to predict, management does not expect the resolution of these legal proceedings to have a material adverse effect on the Company’s financial position, results of operations, or cash flows. The Company has contingent liabilities that, in management’s judgment, are not probable of assertion. If such unasserted contingent liabilities were to be asserted, or become probable of assertion, the Company may be required to record significant expenses and liabilities in the period in which these liabilities are asserted or become probable of assertion.

Income Taxes

Income Taxes	3 Months Ended
	Mar. 31, 2024
Income Tax Disclosure [Abstract]
Income Taxes	(7) Income Taxes The Company computes its year-to-date provision for (benefit from) income taxes by applying the estimated annual effective tax rate to year-to-date pretax income or loss and adjusts the provision for (benefit from) income taxes for discrete tax items recorded in the period. The estimated effective tax rate is subject to fluctuation based on the level and mix of earnings and losses by tax jurisdiction, foreign tax rate differentials, and the relative impact of permanent book to tax differences. Each quarter, a cumulative adjustment is recorded for any fluctuations in the estimated annual effective tax rate as compared to the prior quarter. As a result of these factors, and due to potential changes in the Company’s period-to-period results, fluctuations in the Company’s effective tax rate and respective tax provisions or benefits may occur. For the three months ended March 31, 2024, the Company recorded a benefit from income taxes of $ 160.8 million on a pretax loss of $ 213.9 million, which resulted in an effective tax rate of 75.2 %. For the three months ended March 31, 2023, the Company recorded a benefit from income taxes of $ 453.2 million on a pretax income of $ 8.0 million, which resulted in an effective tax rate of ( 5660.6 ) %. During the three months ended March 31, 2024, the Company’s benefit from income taxes primarily related to (i) a tax benefit related to share-based compensation (including the income tax effects of exercises of stock options and vesting of share-settled restricted stock units) and (ii) a tax benefit from an increase in the Company’s deferred tax asset related to the impairment on its bitcoin holdings. During the three months ended March 31, 2023, the Company’s benefit from income taxes primarily related to the release of a portion of the valuation allowance on the Company’s deferred tax asset related to the impairment on its bitcoin holdings, attributable to the increase in market value of bitcoin as of March 31, 2023 compared to December 31, 2022. As of March 31, 2024 , the Company had a valuation allowance of $1 .4 million primarily related to the Company’s deferred tax assets related to foreign tax credits in certain jurisdictions that, in the Company’s present estimation, more likely than not will not be realized. As of March 31, 2024, the excess of the market value of the Company’s bitcoin over the cost basis of the Company’s bitcoin results in a significant built-in gain for tax purposes and is therefore a source of future taxable income that is expected to allow all of the U.S. net deferred tax assets to be realized. If the market value of bitcoin declines in future periods, the Company would need to assess other sources of forecasted taxable income of proper character, which could result in additional valuation allowances being recorded. The Company will continue to regularly assess the realizability of deferred tax assets. The Company records liabilities related to its uncertain tax positions. As of March 31, 2024 , the Company had gross unrecognized income tax benefits, including accrued interest, of $ 8.2 million, of which $ 6.9 million was recorded in “Other long-term liabilities” and $ 1.3 million was recorded in “Deferred tax assets, net” in the Company’s Consolidated Balance Sheet. As of December 31, 2023 , the Company had gross unrecognized income tax benefits, including accrued interest, of $ 8.3 million, all of which was recorded in “Other long-term liabilities” in the Company’s Consolidated Balance Sheet. As of March 31, 2024 and December 31, 2023 , the Company had income taxes receivable of $ 9.3 million and $ 15.3 million, respectively, recorded in “Prepaid expenses and other current assets” in the Company’s Consolidated Balance Sheets.

Share-based Compensation

Share-based Compensation	3 Months Ended
	Mar. 31, 2024
Share-Based Payment Arrangement [Abstract]
Share-based Compensation	(8) Share-based Compensation Stock Incentive Plans Prior to its expiration, the Company maintained the 2013 Stock Incentive Plan (as amended, the “2013 Equity Plan”), under which the Company’s employees, officers, and directors were awarded various types of share-based compensation, including options to purchase shares of the Company’s class A common stock, restricted stock units, and other stock-based awards. In May 2023 , the 2013 Equity Plan expired and no new awards may be granted under the 2013 Equity Plan, although awards previously granted under the 2013 Equity Plan will continue to remain outstanding in accordance with their terms. The Company maintains the 2023 Equity Incentive Plan, the “2023 Equity Plan”, under which the Company’s employees, officers, directors, and other eligible participants may be awarded various types of share-based compensation, including options to purchase shares of the Company’s class A common stock, restricted stock units, performance stock units, and other stock-based awards. An aggregate of up to 1,932,703 shares of the Company’s class A common stock were authorized for issuance under the 2023 Equity Plan. As of March 31, 2024, there were 231,007 shares of class A common stock reserved and available for future issuance under the 2023 Equity Plan. The 2013 Equity Plan and the 2023 Equity Plan together are referred to herein as the “Stock Incentive Plans.” Stock option awards As of March 31, 2024, there were options to purchase 702,571 shares of class A common stock outstanding under the Stock Incentive Plans. The following table summarizes the Company’s stock option activity (in thousands, except per share data and years) for the three months ended March 31, 2024: Stock Options Outstanding Weighted Average Aggregate Weighted Average Exercise Price Intrinsic Remaining Contractual Shares Per Share Value Term (Years) Balance as of January 1, 2024 1,294 $ 286.78 Granted 9 $ 1,599.29 Exercised ( 583 ) $ 233.42 $ 468,114 Forfeited/Expired ( 17 ) $ 447.47 Balance as of March 31, 2024 703 $ 343.31 Exercisable as of March 31, 2024 385 $ 294.39 $ 542,263 4.8 Expected to vest as of March 31, 2024 318 $ 402.45 $ 414,114 8.0 Total 703 $ 343.31 $ 956,377 6.2 Stock options outstanding as of March 31, 2024 are comprised of the following range of exercise prices per share (in thousands, except per share data and years): Stock Options Outstanding at March 31, 2024 Weighted Average Weighted Average Exercise Price Remaining Contractual Range of Exercise Prices per Share Shares Per Share Term (Years) $ 121.43 - $ 200.00 280 $ 144.01 3.9 $ 200.01 - $ 300.00 108 $ 251.21 8.6 $ 300.01 - $ 400.00 3 $ 301.63 9.2 $ 400.01 - $ 500.00 180 $ 411.49 7.8 $ 600.01 - $ 700.00 123 $ 691.23 6.9 $ 1,500.01 - $ 1,599.29 9 $ 1,599.29 10.0 Total 703 $ 343.31 6.2 An aggregate of 109,250 stock options with an aggregate grant date fair value of $ 32.7 million vested during the three months ended March 31, 2024 . The weighted average grant date fair value of stock option awards using the Black-Scholes valuation model was $ 1,114.42 for each share subject to a stock option granted during the three months ended March 31, 2024, based on the following assumptions: Three months ended March 31, 2024 Expected term of awards in years 6.3 Expected volatility 75.1 % Risk-free interest rate 4.2 % Expected dividend yield 0.0 % No stock option awards were granted during the three months ended March 31, 2023. For the three months ended March 31, 2024 and 2023 , the Company recognized approximately $ 9.8 million and $ 12.9 million, respectively, in share-based compensation expense from stock options granted under the Stock Incentive Plans. As of March 31, 2024 , there was approximately $ 66.5 million of total unrecognized share-based compensation expense related to unvested stock options, which the Company expects to recognize over a weighted average vesting period of approximately 2.1 years. Share-settled restricted stock units As of March 31, 2024, there were 196,830 share-settled restricted stock units outstanding under the Stock Incentive Plans. The following table summarizes the Company’s share-settled restricted stock unit activity (in thousands) for the periods indicated: Share-Settled Restricted Stock Units Outstanding Aggregate Units Intrinsic Value Balance as of January 1, 2024 185 Granted 30 Vested ( 6 ) $ 4,307 Forfeited ( 12 ) Balance as of March 31, 2024 197 Expected to vest as of March 31, 2024 197 $ 335,509 During the three months ended March 31, 2024, 6,002 share-settled restricted stock units having an aggregate grant date fair value of $ 3.2 million vested, and 1,889 shares were withheld to satisfy tax obligations, resulting in 4,113 issued shares. During the three months ended March 31, 2023, 5,780 share-settled restricted stock units having an aggregate grant date fair value of $ 3.4 million vested, and 1,963 shares were withheld to satisfy tax obligations, resulting in 3,817 issued shares. The weighted average grant date fair value of share-settled restricted stock units granted during the three months ended March 31, 2024 and 2023 was $ 1,451.66 and $ 258.65 , respectively, based on the fair value of the Company’s class A common stock. For the three months ended March 31, 2024 and 2023 , the Company recognized approximately $ 4.7 million and $ 3.4 million, respectively, in share-based compensation expense from share-settled restricted stock units granted under the Stock Incentive Plans. As of March 31, 2024 , there was approximately $ 84.1 million of total unrecognized share-based compensation expense related to unvested share-settled restricted stock units, which the Company expects to recognize over a weighted average vesting period of approximately 3.3 years. Share-settled performance stock units As of March 31, 2024, there were 30,285 performance stock units outstanding under the 2023 Equity Plan. The following table summarizes the Company’s performance stock unit activity (in thousands) for the periods indicated: Share-Settled Performance Stock Units Outstanding Aggregate Units Intrinsic Value Balance as of January 1, 2024 25 Granted 6 Vested 0 $ 0 Forfeited ( 1 ) Balance as of March 31, 2024 30 Expected to vest as of March 31, 2024 30 $ 103,245 The weighted average grant date fair value of performance stock units using the Monte-Carlo simulation model was $ 3,071.27 for each performance stock unit granted during the three months ended March 31, 2024 based on the following assumptions: Three months ended March 31, 2024 Expected term of awards in years 3.0 Expected volatility 92.7 % Risk-free interest rate 4.4 % Expected dividend yield 0.0 % No performance stock units were granted during the three months ended March 31, 2023. No performance stock units vested during the three months ended March 31, 2024. For the three months ended March 31, 2024, the Company recognized approximately $ 1.1 million in share-based compensation expense from performance stock units granted under the 2023 Equity Plan. As of March 31, 2024, there was approximately $ 25.8 million of total unrecognized share-based compensation expense related to unvested performance stock units, which the Company expects to recognize over a weighted average vesting period of approximately 2.7 years. Other stock-based awards and cash-settled restricted stock units From time to time the Company has granted “other stock-based awards” and “cash-settled restricted stock units” under the 2013 Equity Plan. Other stock-based awards are similar to stock options, and cash-settled restricted stock units are similar to the Company’s share-settled restricted stock units, except in each case these awards are settled in cash only and not in shares of the Company’s class A common stock. Due to their required cash settlement feature, these awards are classified as liabilities in the Company’s Consolidated Balance Sheets and the fair value of the awards is remeasured each quarterly reporting period. For the three months ended March 31, 2024 and 2023 , the Company recognized approximately $ 1.8 million and $ 0.7 million, respectively, in share-based compensation expense from other stock-based awards and cash-settled restricted stock units. As of March 31, 2024 , there was approximately $ 0.7 million of total unrecognized share-based compensation expense related to other stock-based awards and cash-settled restricted stock units, which the Company expects to recognize over a weighted average vesting period of approximately 0.9 years, subject to additional fair value adjustments through the earlier of settlement or expiration. 2021 ESPP The Company also maintains the 2021 Employee Stock Purchase Plan (the “2021 ESPP”). The purpose of the 2021 ESPP is to provide eligible employees of the Company and certain of its subsidiaries with opportunities to purchase shares of the Company’s class A common stock in 6-month offering periods commencing on each March 1 and September 1. An aggregate of 100,000 shares of the Company’s class A common stock has been authorized for issuance under the 2021 ESPP. During the three months ended March 31, 2024, 6,932 shares of class A common stock were issued in connection with the 2021 ESPP. As of March 31, 2024, 52,675 shares of the Company’s class A common stock remained available for issuance under the 2021 ESPP. For the three months ended March 31, 2024 and 2023, the Company recognized approximately $ 0.4 million and $ 0.6 million, respectively, in share-based compensation expense related to the 2021 ESPP. As of March 31, 2024, there was approximately $ 0.7 million of total unrecognized share-based compensation expense related to the 2021 ESPP, which the Company expects to recognize over a period of approximately 0.4 years. Tax Benefits Related to Equity Plans The following table summarizes the tax benefit related to the Company’s equity plans (in thousands) for the three months ended March 31, 2024 and 2023: Three Months Ended March 31, 2024 2023 Tax benefit related to: Share-based compensation expense $ ( 4,192 ) $ ( 3,225 ) Exercises of stock options and vesting of share-settled restricted stock units ( 104,306 ) ( 85 ) Total tax benefit related to the Company's equity plans $ ( 108,498 ) $ ( 3,310 )

Basic and Diluted (Loss) Earnin

Basic and Diluted (Loss) Earnings per Share	3 Months Ended
	Mar. 31, 2024
Earnings Per Share [Abstract]
Basic and Diluted (Loss) Earnings per Share	(9) Basic and Diluted (Loss) Earnings per Share The Company has two classes of common stock: class A common stock and class B common stock. Holders of class A common stock generally have the same rights, including rights to dividends, as holders of class B common stock, except that holders of class A common stock have one vote per share while holders of class B common stock have ten votes per share. Each share of class B common stock is convertible at any time, at the option of the holder, into one share of class A common stock. As such, basic and fully diluted earnings per share for class A common stock and for class B common stock are the same. The Company has never declared or paid any cash dividends on either class A or class B common stock. As of March 31, 2024 and December 31, 2023 , there were no shares of preferred stock issued or outstanding. The impact from potential shares of common stock on the diluted earnings per share calculation are included when dilutive. Potential shares of class A common stock issuable upon the exercise of outstanding stock options, the vestin g of restricted stock units and performance stock units considered probable of achievement, and in connection with the 2021 ESPP are computed using the treasury stock method. Potential shares of class A common stock issuable upon conversion of the Convertible Notes are computed using the if-converted method. In computing diluted earnings per share, the Company first calculates the earnings per incremental share (“EPIS”) for each class of potential shares of common stock and ranks the classes from the most dilutive (i.e., lowest EPIS) to the least dilutive (i.e., highest EPIS). Basic earnings per share is then adjusted for the effect of each class of shares, in sequence and cumulatively, until a particular class no longer produces further dilution. The following table sets forth the computation of basic and diluted (loss) earnings per share (in thousands, except per share data) for the periods indicated: Three Months Ended March 31, 2024 2023 Numerator: Net (loss) income - Basic $ ( 53,118 ) $ 461,193 Effect of dilutive shares on net (loss) income: Interest expense on 2025 Convertible Notes, net of tax 0 1,414 Interest expense on 2027 Convertible Notes, net of tax 0 720 Interest expense on 2030 Convertible Notes, net of tax 0 0 Interest expense on 2031 Convertible Notes, net of tax 0 0 Net (loss) income - Diluted $ ( 53,118 ) $ 463,327 Denominator: Weighted average common shares of class A common stock 15,230 9,870 Weighted average common shares of class B common stock 1,964 1,964 Total weighted average shares of common stock outstanding - Basic 17,194 11,834 Effect of dilutive shares on weighted average common shares outstanding: Stock options 0 354 Restricted stock units 0 21 Performance stock units 0 0 Employee stock purchase plan 0 0 2025 Convertible Notes 0 1,633 2027 Convertible Notes 0 733 2030 Convertible Notes 0 0 2031 Convertible Notes 0 0 Total weighted average shares of common stock outstanding - Diluted 17,194 14,575 (Loss) earnings per share: Basic (loss) earnings per share (1) $ ( 3.09 ) $ 38.97 Diluted (loss) earnings per share (1) $ ( 3.09 ) $ 31.79 (1) Basic and fully diluted (loss) earnings per share for class A and class B common stock are the same. For the three months ended March 31, 2024 and 2023, the following weighted average shares of potential class A common stock were excluded from the diluted (loss) earnings per share calculation because their impact would have been anti-dilutive (in thousands): Three Months Ended March 31, 2024 2023 Stock options 1,048 711 Restricted stock units 181 42 Performance stock units 52 0 Employee stock purchase plan 1 3 2025 Convertible Notes 1,633 0 2027 Convertible Notes 733 0 2030 Convertible Notes 141 0 2031 Convertible Notes 40 0 Total 3,829 756

At-the-Market Equity Offerings

At-the-Market Equity Offerings	3 Months Ended
	Mar. 31, 2024
At Market Equity Offerings [Abstract]
At-the-Market Equity Offerings	(10) At-the-Market Equity Offerings From time to time, the Company has entered into sales agreements with agents pursuant to which the Company could issue and sell shares of its class A common stock through at-the-market equity offering programs. Pursuant to these agreements, the Company agreed to pay the sales agents commissions for their services in acting as agents with respect to the sale of shares through the at-the-market equity offering programs and also agreed to provide the sales agents with reimbursement for certain incurred expenses and customary indemnification and contribution rights. The following table summarizes the terms and provisions of each sales agreement, and pursuant to each at-the-market equity offering program that was active during 2024 or 2023. The maximum aggregate offering price and cumulative net proceeds (less sales commissions and expenses) for each at-the-market equity offering program in the following table are reported in thousands. November 2023 Sales Agreement August 2023 Sales Agreement May 2023 Sales Agreement 2022 Sales Agreement Agreement effective date November 30, 2023 August 1, 2023 May 1, 2023 September 9, 2022 Sales agents Cowen and Company, LLC, Canaccord Genuity LLC, and BTIG, LLC Cowen and Company, LLC, Canaccord Genuity LLC, and Berenberg Capital Markets LLC Cowen and Company, LLC and Canaccord Genuity LLC Cowen and Company, LLC and BTIG, LLC Maximum aggregate offering price $ 750,000 $ 750,000 $ 625,000 $ 500,000 Maximum commissions payable to sales agents on gross proceeds from the sale of shares 2.0 % 2.0 % 2.0 % 2.0 % Date terminated n/a November 29, 2023 August 1, 2023 May 1, 2023 As of March 31, 2024: Cumulative shares sold under such sales agreement 1,272,077 1,592,950 1,079,170 1,567,430 Cumulative net proceeds received from shares sold under such sales agreement $ 747,025 $ 737,760 $ 333,494 $ 385,181 As of March 31, 2024, the Company has substantially depleted the class A common stock available for issuance and sale pursuant to the sales agreement entered into in November 2023, and terminated each of the other sales agreements referenced above. The following table summarizes the sales activity of each sales agreement that was active during 2024 or 2023 for the periods indicated. The net proceeds (less sales commissions and expenses) for each at-the-market equity offering program in the following table are reported in thousands. Three Months Ended March 31, 2024 2023 Number of shares sold under such sales agreement: 2022 Sales Agreement n/a 1,348,855 May 2023 Sales Agreement n/a n/a August 2023 Sales Agreement n/a n/a November 2023 Sales Agreement 195,162 n/a Total shares sold pursuant to at-the-market equity offering programs 195,162 1,348,855 Net proceeds received from shares sold under such sales agreement: 2022 Sales Agreement n/a $ 338,962 May 2023 Sales Agreement n/a n/a August 2023 Sales Agreement n/a n/a November 2023 Sales Agreement 137,152 n/a Total net proceeds received from shares sold pursuant to at-the-market equity offering programs $ 137,152 $ 338,962 The sales commissions and expenses related to each of the above at-the-market equity offering programs ar e considered direct and incremental costs and are charged against “Additional paid-in capital” on the Consolidated Balance Sheet in the period in which the corresponding shares are issued and sold.

Segment Information

Segment Information	3 Months Ended
	Mar. 31, 2024
Segment Reporting [Abstract]
Segment Information	(11) Segment Information The Company manages its business in one reportable operating segment which is engaged in the design, development, marketing, and sales of its software platform through licensing arrangements and cloud subscriptions and related services. Beginning in 2024, the Company has broken out a Corporate & Other category, which is not considered an operating segment, and includes the impairment charges and other third-party costs associated with the Company’s digital asset holdings. The Company’s chief operating decision maker (“CODM”), who is the Company’s Chief Executive Officer, does not manage the software segment operating results or allocate resources to the software segment when considering these Corporate & Other costs. The following table presents the breakout of the operations of the software segment and the Corporate & Other costs (in thousands): Three Months Ended March 31, 2024 Three Months Ended March 31, 2023 Software Business Corporate & Other Total Consolidated Software Business Corporate & Other Total Consolidated Total revenues $ 115,246 $ 115,246 $ 121,915 $ 121,915 Total cost of revenues 30,015 30,015 27,941 27,941 Gross profit $ 85,231 $ 85,231 $ 93,974 $ 93,974 Total operating expenses 96,123 192,810 288,933 94,487 19,794 114,281 Loss from operations $ ( 10,892 ) $ ( 192,810 ) $ ( 203,702 ) $ ( 513 ) $ ( 19,794 ) $ ( 20,307 ) The following table presents total revenues, gross profit, (loss) income from operations, and long-lived assets (in thousands) according to geographic region. Long-lived assets are comprised of right-of-use assets and property and equipment, net. The Corporate & Other category disclosed above is included within the U.S. region. Geographic regions: U.S. EMEA Other Regions Consolidated Three months ended March 31, 2024 Total revenues $ 64,379 $ 38,353 $ 12,514 $ 115,246 Gross profit $ 46,061 $ 30,900 $ 8,270 $ 85,231 (Loss) income from operations $ ( 211,490 ) $ 13,640 $ ( 5,852 ) $ ( 203,702 ) Three months ended March 31, 2023 Total revenues $ 69,677 $ 38,020 $ 14,218 $ 121,915 Gross profit $ 54,189 $ 29,697 $ 10,088 $ 93,974 (Loss) income from operations $ ( 33,088 ) $ 16,521 $ ( 3,740 ) $ ( 20,307 ) As of March 31, 2024 Long-lived assets $ 74,061 $ 3,486 $ 6,654 $ 84,201 As of December 31, 2023 Long-lived assets $ 75,004 $ 3,937 $ 7,343 $ 86,284 The EMEA region includes operations in Europe, the Middle East, and Africa. The other regions include all other foreign countries, generally comprising Latin America, the Asia Pacific region, and Canada. For the three months ended March 31, 2024 and 2023 , no individual foreign country accounted for 10% or more of total consolidated revenues. For the three months ended March 31, 2024 and 2023 , no individual customer accounted for 10% or more of total consolidated revenues. As of March 31, 2024 and December 31, 2023 , no individual foreign country accounted for 10% or more of total consolidated assets.

Related Party Transactions

Related Party Transactions	3 Months Ended
	Mar. 31, 2024
Related Party Transactions [Abstract]
Related Party Transactions	(12) Related Party Transactions On June 24, 2022, concurrently with binding directors and officers (“D&Os”) liability insurance policies (the “Initial Commercial Policies”) with several third-party carriers, the Company and Michael J. Saylor, the Company’s Chairman of the Board of Directors and Executive Chairman, entered into (i) an indemnification agreement (the “Excess Agreement”) for Mr. Saylor to provide $ 10 million in excess indemnity coverage payable only after the exhaustion of the Initial Commercial Policies, and (ii) an indemnification agreement (the “Tail Agreement”) for Mr. Saylor to provide $ 40 million in indemnity coverage for claims made at any time based on actions or omissions occurring prior to the inception date of the Initial Commercial Policies. The Company paid Mr. Saylor $ 600,000 for a one-year term under the Excess Agreement , and $ 150,000 for a 90-day term under the Tail Agreement . At the option of the Company, the Company was permitted to extend the term under the Tail Agreement for up to a total of twenty-three additional 90 -day periods, for $ 150,000 per additional 90-day term. The Company elected to extend the term of the Tail Agreement for three consecutive additional 90 -day periods and paid Mr. Saylor $ 150,000 for each extension. On August 30, 2022, the Company bound additional D&O liability insurance policies (the “Excess Commercial Policies”) with third-party carriers for excess coverage payable only after the exhaustion of the Initial Commercial Policies. Effective as of the same date, the Company and Mr. Saylor executed an amendment (the “Amendment”) to the Excess Agreement to limit Mr. Saylor’s obligation to provide indemnification under the Excess Agreement to claims made during the term of the Excess Agreement which arise from wrongful acts occurring upon or after the commencement of the Excess Agreement but prior to the effective date of the Amendment. In connection with the Amendment, Mr. Saylor refunded $ 489,863 to the Company, representing the pro rata portion of the $ 600,000 originally paid by the Company to Mr. Saylor under the Excess Agreement attributable to the period from the date of the Amendment through the end of the original term of the Excess Agreement. On June 12, 2023, the Company bound new D&O liability insurance policies (the “2023 Commercial Policies”) with third-party carriers that provide coverage substantially equivalent to the aggregate coverage provided under the Initial Commercial Policies and the Excess Commercial Policies for a policy period running from June 12, 2023 through June 12, 2024 except that the 2023 Commercial Policies also provide coverage for claims made with respect to wrongful acts or omissions occurring prior to the binding of the Initial Commercial Policies subject to exclusions with respect to claims previously noticed to and accepted by an earlier D&O insurer, claims related to acts or omissions giving rise to such claims, and demands, investigations, suits or other proceedings entered against an insured prior to June 24, 2022, as well as future interrelated wrongful acts. On June 12, 2023, the Company entered into a new indemnification agreement with Mr. Saylor (the “2023 Tail Agreement”) pursuant to which Mr. Saylor agreed to provide coverage that is similar to the coverage provided under the Tail Agreement, but only for matters excluded from coverage under the 2023 Commercial Policies for an initial one-year term for a payment of $ 157,000 . The Company may elect, at its option, to extend the term under the 2023 Tail Agreement for up to a total of four additional one-year periods, for $ 157,000 per additional one-year term. The Excess Agreement, Tail Agreement and other related party transactions between the Company and Mr. Saylor are described more fully in Note 17 to the Consolidated Financial Statements of the Company's Annual Report on Form 10-K for the year ended December 31, 2023.

Subsequent Events

Subsequent Events	3 Months Ended
	Mar. 31, 2024
Subsequent Events [Abstract]
Subsequent Events	(13) Subsequent Events Since March 31, 2024 through April 26, 2024, the Company has purchased approximately 122 bitcoins for $ 7.8 million, or approximately $ 63,548 per bitcoin. All of these approximately 122 bitcoins serve as part of the collateral for the 2028 Secured Notes. The Company has incurred at least $ 24.9 million in digital asset impairment losses during the second quarter of 2024 on bitcoin held as of March 31, 2024. See Note 3, Digital Assets , to the Consolidated Financial Statements for further detail on accounting for digital assets.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2024
Accounting Policies [Abstract]
Basis of Presentation	(a) Basis of Presentation The accompanying Consolidated Financial Statements of MicroStrategy Incorporated (“MicroStrategy” or the “Company”) are unaudited. In the opinion of management, all adjustments necessary for a fair statement of financial position and results of operations have been included. All such adjustments are of a normal recurring nature, unless otherwise disclosed. Interim results are not necessarily indicative of results for a full year. The Consolidated Financial Statements and Notes to Consolidated Financial Statements are presented as required by the United States Securities and Exchange Commission (“SEC”) and do not contain certain information included in the Company’s annual financial statements and notes. These financial statements should be read in conjunction with the Company’s audited financial statements and the notes thereto filed with the SEC in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023. There have been no significant changes in the Company’s accounting policies since December 31, 2023. The accompanying Consolidated Financial Statements include the accounts of the Company and its subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation.
Digital Assets	The Company accounts for its digital assets, which are comprised solely of bitcoin, as indefinite-lived intangible assets in accordance with Accounting Standards Codification (“ASC”) 350, Intangibles—Goodwill and Other . The Company’s digital assets are initially recorded at cost. Subsequently, they are measured at cost, net of any impairment losses incurred since acquisition. Impairment losses are recognized as “Digital asset impairment losses” in the Company’s Consolidated Statement of Operations in the period in which the impairment occurs. Gains (if any) are not recorded until realized upon sale, at which point they are presented net of any impairment losses in the Company’s Consolidated Statements of Operations. In determining the gain to be recognized upon sale, the Company calculates the difference between the sales price and carrying value of the specific bitcoins sold immediately prior to sale.
Income Taxes	The Company computes its year-to-date provision for (benefit from) income taxes by applying the estimated annual effective tax rate to year-to-date pretax income or loss and adjusts the provision for (benefit from) income taxes for discrete tax items recorded in the period. The estimated effective tax rate is subject to fluctuation based on the level and mix of earnings and losses by tax jurisdiction, foreign tax rate differentials, and the relative impact of permanent book to tax differences. Each quarter, a cumulative adjustment is recorded for any fluctuations in the estimated annual effective tax rate as compared to the prior quarter.
Basic and Diluted Earnings per Share	The impact from potential shares of common stock on the diluted earnings per share calculation are included when dilutive. Potential shares of class A common stock issuable upon the exercise of outstanding stock options, the vestin g of restricted stock units and performance stock units considered probable of achievement, and in connection with the 2021 ESPP are computed using the treasury stock method. Potential shares of class A common stock issuable upon conversion of the Convertible Notes are computed using the if-converted method. In computing diluted earnings per share, the Company first calculates the earnings per incremental share (“EPIS”) for each class of potential shares of common stock and ranks the classes from the most dilutive (i.e., lowest EPIS) to the least dilutive (i.e., highest EPIS). Basic earnings per share is then adjusted for the effect of each class of shares, in sequence and cumulatively, until a particular class no longer produces further dilution.

Digital Assets (Tables)

Digital Assets (Tables)	3 Months Ended
	Mar. 31, 2024
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Summary of Digital Asset Holdings, Digital Asset Purchases and Digital Asset Impairment Losses	The following table summarizes the Company’s digital asset holdings (in thousands, except number of bitcoins), as of: March 31, December 31, 2024 2023 Approximate number of bitcoins held 214,278 189,150 Digital assets carrying value $ 5,074,152 $ 3,626,476 Cumulative digital asset impairment losses $ 2,460,646 $ 2,269,013 The following table summarizes the Company’s digital asset purchases and digital asset impairment losses (in thousands, except number of bitcoins) for the periods indicated. The Company did no t sell any of its bitcoins during the three months ended March 31, 2024 or 2023, respectively. Three Months Ended March 31, 2024 2023 Approximate number of bitcoins purchased 25,128 7,500 Digital asset purchases $ 1,639,309 $ 179,275 Digital asset impairment losses $ 191,633 $ 18,911

Contract Balances (Tables)

Contract Balances (Tables)	3 Months Ended
	Mar. 31, 2024
Contract with Customer, Contract Asset, Contract Liability, and Receivable [Abstract]
Schedule of Accounts Receivable	Accounts receivable (in thousands) consisted of the following, as of: March 31, December 31, 2024 2023 Billed and billable $ 117,257 $ 186,884 Less: allowance for credit losses ( 2,107 ) ( 3,069 ) Accounts receivable, net $ 115,150 $ 183,815
Deferred Revenue and Advance Payments	Deferred revenue and advance payments (in thousands) from customers consisted of the following, as of: March 31, December 31, 2024 2023 Current: Deferred product licenses revenue $ 2,879 $ 3,579 Deferred subscription services revenue 60,280 65,512 Deferred product support revenue 148,078 152,012 Deferred other services revenue 4,718 7,059 Total current deferred revenue and advance payments $ 215,955 $ 228,162 Non-current: Deferred product licenses revenue $ 0 $ 0 Deferred subscription services revenue 1,992 3,097 Deferred product support revenue 4,094 4,984 Deferred other services revenue 400 443 Total non-current deferred revenue and advance payments $ 6,486 $ 8,524

Long-term Debt (Tables)

Long-term Debt (Tables)	3 Months Ended
	Mar. 31, 2024
Debt Instrument [Line Items]
Schedule of Debt	The net carrying value of the Company’s long-term debt (in thousands) consisted of the following, as of: March 31, 2024 December 31, 2023 2025 Convertible Notes $ 644,698 $ 643,931 2027 Convertible Notes 1,038,316 1,037,306 2030 Convertible Notes 782,248 0 2031 Convertible Notes 592,368 0 2028 Secured Notes 491,622 491,193 Other long-term secured debt 9,549 9,678 Total $ 3,558,801 $ 2,182,108
Summary of Periods that Each of the Convertible Notes Were Convertible at the Option of Holders	The following summarizes which periods, if any, that each of the Convertible Notes were convertible at the option of the holders during the three months ended March 31, 2024 and 2023: Three Months Ended March 31, 2024 2023 2025 Convertible Notes Convertible Not convertible at any time 2027 Convertible Notes Not convertible at any time Not convertible at any time 2030 Convertible Notes Not convertible at any time n/a 2031 Convertible Notes Not convertible at any time n/a
Schedule of Net Carrying Amount of Liability and Equity Component of Convertible Senior Notes	The following is a summary of the Company’s convertible debt instruments as of March 31, 2024 (in thousands): March 31, 2024 Outstanding Unamortized Net Carrying Fair Value Principal Amount Issuance Costs Value Amount Leveling 2025 Convertible Notes $ 650,000 $ ( 5,302 ) $ 644,698 $ 2,847,274 Level 2 2027 Convertible Notes 1,050,000 ( 11,684 ) 1,038,316 1,437,616 Level 2 2030 Convertible Notes 800,000 ( 17,752 ) 782,248 1,064,727 Level 2 2031 Convertible Notes 603,750 ( 11,382 ) 592,368 638,466 Level 2 Total $ 3,103,750 $ ( 46,120 ) $ 3,057,630 $ 5,988,083 The following is a summary of the Company’s convertible debt instruments as of December 31, 2023 (in thousands): December 31, 2023 Outstanding Unamortized Net Carrying Fair Value Principal Amount Issuance Costs Value Amount Leveling 2025 Convertible Notes $ 650,000 $ ( 6,069 ) $ 643,931 $ 1,074,713 Level 2 2027 Convertible Notes 1,050,000 ( 12,694 ) 1,037,306 913,808 Level 2 Total $ 1,700,000 $ ( 18,763 ) $ 1,681,237 $ 1,988,521
Schedule of Maturities of Debt Instruments	Maturities The following table shows the maturities of the Company’s debt instruments as of March 31, 2024 (in thousands). The principal payments related to the 2028 Secured Notes are included in the table below based on the First Springing Maturity Date of September 15, 2025, as if the springing maturity feature discussed above were triggered. As of March 31, 2024, the Company expects to be able to satisfy the requirements in the 2028 Secured Notes Indenture to avoid triggering the springing maturity feature of the 2028 Secured Notes. The principal payments related to the 2030 Convertible Notes and 2031 Convertible Notes, respectively, are included in the table below as if the holders exercised their right to require the Company to repurchase all of the 2030 Convertible Notes and 2031 Convertible Notes on September 15, 2028. Payments due by period ended March 31, 2025 Convertible Notes 2027 Convertible Notes 2030 Convertible Notes 2031 Convertible Notes 2028 Secured Notes Other long-term secured debt Total 2025 $ 0 $ 0 $ 0 $ 0 $ 0 $ 547 $ 547 2026 650,000 0 0 0 500,000 577 1,150,577 2027 0 1,050,000 0 0 0 608 1,050,608 2028 0 0 0 0 0 8,477 8,477 2029 0 0 800,000 603,750 0 0 1,403,750 Thereafter 0 0 0 0 0 0 0 Total $ 650,000 $ 1,050,000 $ 800,000 $ 603,750 $ 500,000 $ 10,209 $ 3,613,959
Secured Notes Due Twenty Twenty Eight
Debt Instrument [Line Items]
Schedule of Debt	The following is a summary of the 2028 Secured Notes as of March 31, 2024 (in thousands): March 31, 2024 Outstanding Unamortized Net Carrying Fair Value Principal Amount Issuance Costs Value Amount Leveling 2028 Secured Notes $ 500,000 $ ( 8,378 ) $ 491,622 $ 483,125 Level 2 The following is a summary of the 2028 Secured Notes as of December 31, 2023 (in thousands): December 31, 2023 Outstanding Unamortized Net Carrying Fair Value Principal Amount Issuance Costs Value Amount Leveling 2028 Secured Notes $ 500,000 $ ( 8,807 ) $ 491,193 $ 485,070 Level 2
Schedule of Interest Expense Related to Notes	For the three months ended March 31, 2024 and 2023, interest expense related to the 2028 Secured Notes was as follows (in thousands): Three Months Ended March 31, 2024 Three Months Ended March 31, 2023 Contractual Amortization of Contractual Amortization of Interest Expense Issuance Costs Total Interest Expense Issuance Costs Total 2028 Secured Notes $ 7,656 $ 429 $ 8,085 $ 7,656 $ 401 $ 8,057
Term Loan Due Twenty Twenty Five
Debt Instrument [Line Items]
Schedule of Interest Expense Related to Notes	For the three months ended March 31, 2023, interest expense related to the 2025 Secured Term Loan was as follows (in thousands): Three Months Ended March 31, 2023 Contractual Amortization of Interest Expense Issuance Costs Total 2025 Secured Term Loan $ 3,781 $ 31 $ 3,812
Convertible Debt
Debt Instrument [Line Items]
Schedule of Interest Expense Related to Notes	For the three months ended March 31, 2024 and 2023, interest expense related to the Convertible Notes was as follows (in thousands): Three Months Ended March 31, 2024 Three Months Ended March 31, 2023 Contractual Amortization of Contractual Amortization of Interest Expense Issuance Costs Total Interest Expense Issuance Costs Total 2025 Convertible Notes $ 1,219 $ 767 $ 1,986 $ 1,219 $ 757 $ 1,976 2027 Convertible Notes 0 1,010 1,010 0 1,006 1,006 2030 Convertible Notes 319 248 567 0 0 0 2031 Convertible Notes 191 89 280 0 0 0 Total $ 1,729 $ 2,114 $ 3,843 $ 1,219 $ 1,763 $ 2,982

Share-based Compensation (Table

Share-based Compensation (Tables)	3 Months Ended
	Mar. 31, 2024
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Summary of Stock Option Activity	The following table summarizes the Company’s stock option activity (in thousands, except per share data and years) for the three months ended March 31, 2024: Stock Options Outstanding Weighted Average Aggregate Weighted Average Exercise Price Intrinsic Remaining Contractual Shares Per Share Value Term (Years) Balance as of January 1, 2024 1,294 $ 286.78 Granted 9 $ 1,599.29 Exercised ( 583 ) $ 233.42 $ 468,114 Forfeited/Expired ( 17 ) $ 447.47 Balance as of March 31, 2024 703 $ 343.31 Exercisable as of March 31, 2024 385 $ 294.39 $ 542,263 4.8 Expected to vest as of March 31, 2024 318 $ 402.45 $ 414,114 8.0 Total 703 $ 343.31 $ 956,377 6.2
Schedule of Range of Exercise Prices per Share	Stock options outstanding as of March 31, 2024 are comprised of the following range of exercise prices per share (in thousands, except per share data and years): Stock Options Outstanding at March 31, 2024 Weighted Average Weighted Average Exercise Price Remaining Contractual Range of Exercise Prices per Share Shares Per Share Term (Years) $ 121.43 - $ 200.00 280 $ 144.01 3.9 $ 200.01 - $ 300.00 108 $ 251.21 8.6 $ 300.01 - $ 400.00 3 $ 301.63 9.2 $ 400.01 - $ 500.00 180 $ 411.49 7.8 $ 600.01 - $ 700.00 123 $ 691.23 6.9 $ 1,500.01 - $ 1,599.29 9 $ 1,599.29 10.0 Total 703 $ 343.31 6.2
Assumptions Used in Pricing Model	The weighted average grant date fair value of stock option awards using the Black-Scholes valuation model was $ 1,114.42 for each share subject to a stock option granted during the three months ended March 31, 2024, based on the following assumptions: Three months ended March 31, 2024 Expected term of awards in years 6.3 Expected volatility 75.1 % Risk-free interest rate 4.2 % Expected dividend yield 0.0 %
Summary of Share-Settled Restricted Stock Unit Activity	The following table summarizes the Company’s share-settled restricted stock unit activity (in thousands) for the periods indicated: Share-Settled Restricted Stock Units Outstanding Aggregate Units Intrinsic Value Balance as of January 1, 2024 185 Granted 30 Vested ( 6 ) $ 4,307 Forfeited ( 12 ) Balance as of March 31, 2024 197 Expected to vest as of March 31, 2024 197 $ 335,509
Summary of Share-Settled Performance Stock Unit Activity	As of March 31, 2024, there were 30,285 performance stock units outstanding under the 2023 Equity Plan. The following table summarizes the Company’s performance stock unit activity (in thousands) for the periods indicated: Share-Settled Performance Stock Units Outstanding Aggregate Units Intrinsic Value Balance as of January 1, 2024 25 Granted 6 Vested 0 $ 0 Forfeited ( 1 ) Balance as of March 31, 2024 30 Expected to vest as of March 31, 2024 30 $ 103,245
Summary of Components of Tax Benefit Related To Equity Plan	The following table summarizes the tax benefit related to the Company’s equity plans (in thousands) for the three months ended March 31, 2024 and 2023: Three Months Ended March 31, 2024 2023 Tax benefit related to: Share-based compensation expense $ ( 4,192 ) $ ( 3,225 ) Exercises of stock options and vesting of share-settled restricted stock units ( 104,306 ) ( 85 ) Total tax benefit related to the Company's equity plans $ ( 108,498 ) $ ( 3,310 )
Share-settled Performance Stock Units
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Assumptions Used in Pricing Model	The weighted average grant date fair value of performance stock units using the Monte-Carlo simulation model was $ 3,071.27 for each performance stock unit granted during the three months ended March 31, 2024 based on the following assumptions: Three months ended March 31, 2024 Expected term of awards in years 3.0 Expected volatility 92.7 % Risk-free interest rate 4.4 % Expected dividend yield 0.0 %

Basic and Diluted (Loss) Earn_2

Basic and Diluted (Loss) Earnings per Share (Tables)	3 Months Ended
	Mar. 31, 2024
Earnings Per Share [Abstract]
Computation of Basic and Diluted (Loss) Earnings per Share	The following table sets forth the computation of basic and diluted (loss) earnings per share (in thousands, except per share data) for the periods indicated: Three Months Ended March 31, 2024 2023 Numerator: Net (loss) income - Basic $ ( 53,118 ) $ 461,193 Effect of dilutive shares on net (loss) income: Interest expense on 2025 Convertible Notes, net of tax 0 1,414 Interest expense on 2027 Convertible Notes, net of tax 0 720 Interest expense on 2030 Convertible Notes, net of tax 0 0 Interest expense on 2031 Convertible Notes, net of tax 0 0 Net (loss) income - Diluted $ ( 53,118 ) $ 463,327 Denominator: Weighted average common shares of class A common stock 15,230 9,870 Weighted average common shares of class B common stock 1,964 1,964 Total weighted average shares of common stock outstanding - Basic 17,194 11,834 Effect of dilutive shares on weighted average common shares outstanding: Stock options 0 354 Restricted stock units 0 21 Performance stock units 0 0 Employee stock purchase plan 0 0 2025 Convertible Notes 0 1,633 2027 Convertible Notes 0 733 2030 Convertible Notes 0 0 2031 Convertible Notes 0 0 Total weighted average shares of common stock outstanding - Diluted 17,194 14,575 (Loss) earnings per share: Basic (loss) earnings per share (1) $ ( 3.09 ) $ 38.97 Diluted (loss) earnings per share (1) $ ( 3.09 ) $ 31.79 (1) Basic and fully diluted (loss) earnings per share for class A and class B common stock are the same.
Schedule of Weighted Average of Potential Class A Common Stock Excluded from Computation of (Loss) Earnings Per Share	For the three months ended March 31, 2024 and 2023, the following weighted average shares of potential class A common stock were excluded from the diluted (loss) earnings per share calculation because their impact would have been anti-dilutive (in thousands): Three Months Ended March 31, 2024 2023 Stock options 1,048 711 Restricted stock units 181 42 Performance stock units 52 0 Employee stock purchase plan 1 3 2025 Convertible Notes 1,633 0 2027 Convertible Notes 733 0 2030 Convertible Notes 141 0 2031 Convertible Notes 40 0 Total 3,829 756

At-the-Market Equity Offerings

At-the-Market Equity Offerings (Tables)	3 Months Ended
	Mar. 31, 2024
At Market Equity Offerings [Abstract]
Summary of Active At-the-Market Equity Offering	The following table summarizes the terms and provisions of each sales agreement, and pursuant to each at-the-market equity offering program that was active during 2024 or 2023. The maximum aggregate offering price and cumulative net proceeds (less sales commissions and expenses) for each at-the-market equity offering program in the following table are reported in thousands. November 2023 Sales Agreement August 2023 Sales Agreement May 2023 Sales Agreement 2022 Sales Agreement Agreement effective date November 30, 2023 August 1, 2023 May 1, 2023 September 9, 2022 Sales agents Cowen and Company, LLC, Canaccord Genuity LLC, and BTIG, LLC Cowen and Company, LLC, Canaccord Genuity LLC, and Berenberg Capital Markets LLC Cowen and Company, LLC and Canaccord Genuity LLC Cowen and Company, LLC and BTIG, LLC Maximum aggregate offering price $ 750,000 $ 750,000 $ 625,000 $ 500,000 Maximum commissions payable to sales agents on gross proceeds from the sale of shares 2.0 % 2.0 % 2.0 % 2.0 % Date terminated n/a November 29, 2023 August 1, 2023 May 1, 2023 As of March 31, 2024: Cumulative shares sold under such sales agreement 1,272,077 1,592,950 1,079,170 1,567,430 Cumulative net proceeds received from shares sold under such sales agreement $ 747,025 $ 737,760 $ 333,494 $ 385,181
Summary of Sales Activity of Sales Agreement for At-the-Market Equity Offering	The following table summarizes the sales activity of each sales agreement that was active during 2024 or 2023 for the periods indicated. The net proceeds (less sales commissions and expenses) for each at-the-market equity offering program in the following table are reported in thousands. Three Months Ended March 31, 2024 2023 Number of shares sold under such sales agreement: 2022 Sales Agreement n/a 1,348,855 May 2023 Sales Agreement n/a n/a August 2023 Sales Agreement n/a n/a November 2023 Sales Agreement 195,162 n/a Total shares sold pursuant to at-the-market equity offering programs 195,162 1,348,855 Net proceeds received from shares sold under such sales agreement: 2022 Sales Agreement n/a $ 338,962 May 2023 Sales Agreement n/a n/a August 2023 Sales Agreement n/a n/a November 2023 Sales Agreement 137,152 n/a Total net proceeds received from shares sold pursuant to at-the-market equity offering programs $ 137,152 $ 338,962

Segment Information (Tables)

Segment Information (Tables)	3 Months Ended
	Mar. 31, 2024
Segment Reporting [Abstract]
Breakout of Operations of Software Segment and Corporate & Other Costs	The following table presents the breakout of the operations of the software segment and the Corporate & Other costs (in thousands): Three Months Ended March 31, 2024 Three Months Ended March 31, 2023 Software Business Corporate & Other Total Consolidated Software Business Corporate & Other Total Consolidated Total revenues $ 115,246 $ 115,246 $ 121,915 $ 121,915 Total cost of revenues 30,015 30,015 27,941 27,941 Gross profit $ 85,231 $ 85,231 $ 93,974 $ 93,974 Total operating expenses 96,123 192,810 288,933 94,487 19,794 114,281 Loss from operations $ ( 10,892 ) $ ( 192,810 ) $ ( 203,702 ) $ ( 513 ) $ ( 19,794 ) $ ( 20,307 )
Total Revenues, Gross Profit, (Loss) Income from Operations, and Long-Lived Assets, by Geographic Region	The following table presents total revenues, gross profit, (loss) income from operations, and long-lived assets (in thousands) according to geographic region. Long-lived assets are comprised of right-of-use assets and property and equipment, net. The Corporate & Other category disclosed above is included within the U.S. region. Geographic regions: U.S. EMEA Other Regions Consolidated Three months ended March 31, 2024 Total revenues $ 64,379 $ 38,353 $ 12,514 $ 115,246 Gross profit $ 46,061 $ 30,900 $ 8,270 $ 85,231 (Loss) income from operations $ ( 211,490 ) $ 13,640 $ ( 5,852 ) $ ( 203,702 ) Three months ended March 31, 2023 Total revenues $ 69,677 $ 38,020 $ 14,218 $ 121,915 Gross profit $ 54,189 $ 29,697 $ 10,088 $ 93,974 (Loss) income from operations $ ( 33,088 ) $ 16,521 $ ( 3,740 ) $ ( 20,307 ) As of March 31, 2024 Long-lived assets $ 74,061 $ 3,486 $ 6,654 $ 84,201 As of December 31, 2023 Long-lived assets $ 75,004 $ 3,937 $ 7,343 $ 86,284

Recent Accounting Standards - A

Recent Accounting Standards - Additional Information (Detail) $ in Billions	Jan. 01, 2024 USD ($)
ASU 2023-08
New Accounting Pronouncements Or Change In Accounting Principle [Line Items]
Increase in retained earnings	$ 3.1

Digital Assets - Summary of Dig

Digital Assets - Summary of Digital Asset Holdings (Details) $ in Thousands	Mar. 31, 2024 USD ($) Bitcoin	Dec. 31, 2023 USD ($) Bitcoin
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Approximate number of bitcoins held | Bitcoin	214,278	189,150
Digital assets	$ 5,074,152	$ 3,626,476
Cumulative digital asset impairment losses	$ 2,460,646	$ 2,269,013

Digital Assets - Summary of D_2

Digital Assets - Summary of Digital Asset Purchases and Digital Asset Impairment Losses (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2024 USD ($) Bitcoin	Mar. 31, 2023 USD ($) Bitcoin
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Approximate number of bitcoins purchased | Bitcoin	25,128	7,500
Digital asset purchases	$ 1,639,309	$ 179,275
Digital asset impairment losses	$ 191,633	$ 18,911

Digital Assets - Additional Inf

Digital Assets - Additional Information (Detail)	3 Months Ended		12 Months Ended
	Mar. 31, 2024 USD ($) Bitcoin	Mar. 31, 2023 Bitcoin	Dec. 31, 2023 USD ($) Bitcoin
Digital Assets [Line Items]
Number of bitcoins sold | Bitcoin	0	0
Trade credit payable, outstanding	$ 0
Carrying value of bitcoin held by the company	$ 5,074,152,000		$ 3,626,476,000
Secured Notes Due Twenty Twenty Eight
Digital Assets [Line Items]
Number of digital assets held as collateral for 2028 Secured Notes | Bitcoin	38,557		16,081
Interest rate, fixed percentage	6.125%
Carrying value of bitcoin held by the company	$ 1,606,000,000		$ 263,900,000

Contract Balances - Schedule of

Contract Balances - Schedule of Accounts Receivable (Detail) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Receivables [Abstract]
Billed and billable	$ 117,257	$ 186,884
Less: allowance for credit losses	(2,107)	(3,069)
Accounts receivable, net	$ 115,150	$ 183,815

Contract Balances - Additional

Contract Balances - Additional Information (Detail) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
Contract With Customer Asset And Liability [Line Items]
Revenue, Remaining performance obligation	$ 338,100,000
Prepaid Expenses and Other Current Assets
Contract With Customer Asset And Liability [Line Items]
Non-current contract assets	1,500,000		$ 1,200,000
Deposits And Other Assets
Contract With Customer Asset And Liability [Line Items]
Current contract assets	2,700,000		$ 900,000
Current Deferred Revenue and Advanced Payments
Contract With Customer Asset And Liability [Line Items]
Revenue recognized from beginning deferred revenue	80,800,000	$ 80,700,000
Contract Assets
Contract With Customer Asset And Liability [Line Items]
Assets impairment charges	$ 0	$ 0

Contract Balances - Deferred Re

Contract Balances - Deferred Revenue and Advance Payments (Detail) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Deferred Revenue Disclosure [Abstract]
Deferred product licenses revenue, Current	$ 2,879	$ 3,579
Deferred subscription services revenue, Current	60,280	65,512
Deferred product support revenue, Current	148,078	152,012
Deferred other services revenue, Current	4,718	7,059
Total current deferred revenue and advance payments	215,955	228,162
Deferred product licenses revenue, Non-current	0	0
Deferred subscription services revenue, Non-current	1,992	3,097
Deferred product support revenue, Non-current	4,094	4,984
Deferred other services revenue, Non-current	400	443
Total non-current deferred revenue and advance payments	$ 6,486	$ 8,524

Contract Balances - Additiona_2

Contract Balances - Additional Information (Detail1) $ in Millions	Mar. 31, 2024 USD ($)
Contract With Customer Asset And Liability [Line Items]
Revenue, Remaining performance obligation	$ 338.1
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2024-04-01
Contract With Customer Asset And Liability [Line Items]
Revenue, Remaining performance obligations, Expected timing of satisfaction, Period	12 months
Revenue, Remaining performance obligation	$ 247.5
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2025-04-01
Contract With Customer Asset And Liability [Line Items]
Revenue, Remaining performance obligations, Expected timing of satisfaction, Period

Long-term Debt - Schedule of Ne

Long-term Debt - Schedule of Net Carrying Amount of Long-term Debt (Detail) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Debt Instrument [Line Items]
Total	$ 3,558,801	$ 2,182,108
Convertible Senior Notes due 2025 | Convertible Debt
Debt Instrument [Line Items]
Total	644,698	643,931
Convertible Senior Notes due 2027 | Convertible Debt
Debt Instrument [Line Items]
Total	1,038,316	1,037,306
Convertible Senior Notes due 2030 | Convertible Debt
Debt Instrument [Line Items]
Total	782,248	0
Convertible Senior Notes due 2031 | Convertible Debt
Debt Instrument [Line Items]
Total	592,368	0
Secured Notes Due Twenty Twenty Eight
Debt Instrument [Line Items]
Total	491,622	491,193
Other Long-Term Secured Debt
Debt Instrument [Line Items]
Total	$ 9,549	$ 9,678

Long-term Debt - Additional Inf

Long-term Debt - Additional Information (Detail)				1 Months Ended				3 Months Ended
	Sep. 15, 2028	Mar. 24, 2023 USD ($)	Jun. 14, 2021 USD ($)	Mar. 31, 2024 USD ($) Days Bitcoin $ / shares shares	Jun. 30, 2022 USD ($)	Feb. 28, 2021 USD ($)	Dec. 31, 2020 USD ($)	Mar. 31, 2024 USD ($) TradingDay Bitcoin $ / shares shares	Mar. 31, 2023 USD ($)	Dec. 31, 2023 USD ($)	Mar. 23, 2022 USD ($)
Debt Instrument [Line Items]
Convertible notes redeemed				$ 0				$ 0
Payment to extinguishment of debt								0	$ 159,900,000
Gain on extinguishment of debt								0	44,686,000
Current portion of long-term debt, net				492,000				492,000		$ 483,000
Senior Secured Notes Due Twenty Twenty Eight
Debt Instrument [Line Items]
Debt Instrument, Face Amount			$ 500,000,000
Interest rate, fixed percentage			6.125%
Periodic payment description			The 2028 Secured Notes bear interest at a fixed rate of 6.125% per annum, payable semiannually in arrears on June 15 and December 15 of each year, beginning on December 15, 2021.
Payment start date			Dec. 15, 2021
Secured notes redeemed				$ 0				$ 0
Debt instrument, maturity date			Jun. 15, 2028
Debt instrument, first springing maturity date			Sep. 15, 2025
Debt instrument, second springing maturity date			Nov. 16, 2026
Convertible Senior Notes due 2025
Debt Instrument [Line Items]
Debt Instrument, Face Amount							$ 650,000,000
Interest rate, fixed percentage							0.75%
Periodic payment description							The 2025 Convertible Notes are senior unsecured obligations of the Company and bear interest at a fixed rate of 0.750% per annum, payable semiannually in arrears on June 15 and December 15 of each year, beginning on June 15, 2021.
Payment start date							Jun. 15, 2021
Debt instrument, maturity date							Dec. 15, 2025
Number of shares convertible from notes | shares				1,633,190				1,633,190
Total Interest Paid								$ 0	0
Convertible Senior Notes due 2025 | Class A
Debt Instrument [Line Items]
Debt instrument, convertible, trading days | TradingDay								20
Debt instrument, convertible, consecutive trading days | TradingDay								30
Convertible Senior Notes due 2025 | Class A | Minimum
Debt Instrument [Line Items]
Conversion price percentage applicable trading days								130%
Convertible Senior Notes due 2027
Debt Instrument [Line Items]
Debt Instrument, Face Amount						$ 1,050,000,000
Interest rate, fixed percentage						0%
Periodic payment description						The 2027 Convertible Notes are senior unsecured obligations of the Company and do not bear regular interest. However, holders of the 2027 Convertible Notes may receive special interest under specified circumstances as outlined in the indenture relating to the issuance of the 2027 Convertible Notes. Any special interest is payable semiannually in arrears on February 15 and August 15 of each year, beginning on August 15, 2021
Payment start date						Aug. 15, 2021
Debt instrument, maturity date						Feb. 15, 2027
Number of shares convertible from notes | shares				733,005				733,005
Convertible Senior Notes due 2030
Debt Instrument [Line Items]
Debt Instrument, Face Amount				$ 800				$ 800
Interest rate, fixed percentage				0.625%				0.625%
Periodic payment description				The 2030 Convertible Notes are senior unsecured obligations of the Company and bear interest at a fixed rate of 0.625% per annum, payable semiannually in arrears on March 15 and September 15 of each year, beginning on September 15, 2024. Holders of the 2030 Convertible Notes may receive additional interest under specified circumstances as outlined in the indenture relating to the issuance of the 2030 Convertible Notes (the “2030 Convertible Notes Indenture”).
Payment start date				Sep. 15, 2024
Proceeds from debt				$ 782,000,000
Customary offering expense				$ 18,000,000				$ 18,000,000
Effective interest rate percentage				1.14%				1.14%
Debt instrument, maturity date				Mar. 15, 2030
Number of shares convertible from notes | shares				534,160				534,160
Convertible Senior Notes due 2030 | Scenario Forecast
Debt Instrument [Line Items]
Debt instrument, redemption price, percentage of principal amount redeemed	100%
Convertible Senior Notes due 2030 | Fundamental Change
Debt Instrument [Line Items]
Debt instrument, redemption price, percentage of principal amount redeemed				100%
Convertible Senior Notes due 2030 | Events of Default
Debt Instrument [Line Items]
Percentage of principal accrued and unpaid interest				100%
Convertible Senior Notes due 2030 | Events of Default | Minimum
Debt Instrument [Line Items]
Minimum percentage principal amount of holders required to declare the principal of, and accrued and unpaid interest, on Notes is due and payable upon an event of default				25%
Convertible Senior Notes due 2030 | Class A
Debt Instrument [Line Items]
Initial conversion rate				0.6677
Price per share | $ / shares				$ 1,000				$ 1,000
Initial conversion price | $ / shares				$ 1,497.68				1,497.68
Convertible Senior Notes due 2030 | Class A | Redeemable by Company after December 20, 2023
Debt Instrument [Line Items]
Debt instrument, redemption price, percentage of principal amount redeemed				100%
Debt instrument, convertible, earliest date				Mar. 22, 2027
Debt instrument, convertible, trading days | Days				20
Debt instrument, convertible, consecutive trading days | Days				30
Convertible Senior Notes due 2030 | Class A | Redeemable by Company after February 20, 2024 | Minimum
Debt Instrument [Line Items]
Conversion price percentage applicable trading days				130%
Convertible Senior Notes due 2030 | Class A | Early Conversion by Noteholders before September 15, 2029
Debt Instrument [Line Items]
Debt instrument, convertible, earliest date				Sep. 15, 2029
Debt instrument, convertible, trading days | Days				20
Debt instrument, convertible, consecutive trading days | Days				30
Convertible Senior Notes due 2030 | Class A | Early Conversion by Noteholders before September 15, 2029 | Minimum
Debt Instrument [Line Items]
Conversion price percentage applicable trading days				130%
Convertible Senior Notes due 2030 | Class A | Early Conversion by Noteholders before September 15, 2029
Debt Instrument [Line Items]
Debt instrument, convertible, trading days | Days				5
Trading price per share | $ / shares				$ 1,000				$ 1,000
Debt instrument, convertible, consecutive trading days | Days				5
Convertible Senior Notes due 2030 | Class A | Early Conversion by Noteholders before September 15, 2029 | Maximum
Debt Instrument [Line Items]
Conversion price percentage applicable trading days				98%
Convertible Senior Notes due 2031
Debt Instrument [Line Items]
Debt Instrument, Face Amount				$ 603,800,000				$ 603,800,000
Interest rate, fixed percentage				0.875%				0.875%
Periodic payment description				The 2031 Convertible Notes are senior unsecured obligations of the Company and bear interest at a fixed rate of 0.875% per annum, payable semiannually in arrears on March 15 and September 15 of each year, beginning on September 15, 2024. Holders of the 2031 Convertible Notes may receive additional interest under specified circumstances as outlined in the indenture relating to the issuance of the 2031 Convertible Notes (the “2031 Convertible Notes Indenture”).
Payment start date				Sep. 15, 2024
Proceeds from debt				$ 592,300,000
Customary offering expense				$ 11,500,000				$ 11,500,000
Effective interest rate percentage				1.31%				1.31%
Debt instrument, maturity date				Mar. 15, 2031
Number of shares convertible from notes | shares				259,431				259,431
Convertible Senior Notes due 2031 | Scenario Forecast
Debt Instrument [Line Items]
Debt instrument, redemption price, percentage of principal amount redeemed	100%
Convertible Senior Notes due 2031 | Fundamental Change
Debt Instrument [Line Items]
Debt instrument, redemption price, percentage of principal amount redeemed				100%
Convertible Senior Notes due 2031 | Events of Default
Debt Instrument [Line Items]
Percentage of principal accrued and unpaid interest				100%
Convertible Senior Notes due 2031 | Events of Default | Minimum
Debt Instrument [Line Items]
Minimum percentage principal amount of holders required to declare the principal of, and accrued and unpaid interest, on Notes is due and payable upon an event of default				25%
Convertible Senior Notes due 2031 | Class A
Debt Instrument [Line Items]
Initial conversion rate				0.4297
Price per share | $ / shares				$ 1,000				$ 1,000
Initial conversion price | $ / shares				$ 2,327.21				2,327.21
Convertible Senior Notes due 2031 | Class A | Redeemable by Company after December 20, 2023
Debt Instrument [Line Items]
Debt instrument, redemption price, percentage of principal amount redeemed				100%
Debt instrument, convertible, trading days | Days				20
Debt instrument, convertible, consecutive trading days | Days				30
Convertible Senior Notes due 2031 | Class A | Redeemable by Company after February 20, 2024
Debt Instrument [Line Items]
Debt instrument, convertible, earliest date				Mar. 22, 2028
Convertible Senior Notes due 2031 | Class A | Redeemable by Company after February 20, 2024 | Minimum
Debt Instrument [Line Items]
Conversion price percentage applicable trading days				130%
Convertible Senior Notes due 2031 | Class A | Early Conversion by Noteholders before September 15, 2030
Debt Instrument [Line Items]
Debt instrument, convertible, trading days | Days				5
Trading price per share | $ / shares				$ 1,000				$ 1,000
Debt instrument, convertible, consecutive trading days | Days				5
Convertible Senior Notes due 2031 | Class A | Early Conversion by Noteholders before September 15, 2030 | Maximum
Debt Instrument [Line Items]
Conversion price percentage applicable trading days				98%
Convertible Senior Notes due 2031 | Class A | Early Conversion by Noteholders before September 15, 2030
Debt Instrument [Line Items]
Debt instrument, convertible, earliest date				Sep. 15, 2030
Debt instrument, convertible, trading days | Days				20
Debt instrument, convertible, consecutive trading days | Days				30
Convertible Senior Notes due 2031 | Class A | Early Conversion by Noteholders before September 15, 2030 | Minimum
Debt Instrument [Line Items]
Conversion price percentage applicable trading days				130%
Convertible Senior Notes due 2027
Debt Instrument [Line Items]
Total Interest Paid								$ 0	0
Secured Notes Due Twenty Twenty Eight
Debt Instrument [Line Items]
Interest rate, fixed percentage				6.125%				6.125%
Total Interest Paid								$ 0	0
Interest expense								$ 7,656,000	7,656,000
Debt instrument, first springing maturity date			Sep. 15, 2025
Debt instrument, second springing maturity date			Nov. 16, 2026
Unencumbered existing digital assets | Bitcoin				92,079				92,079
Secured Notes Due Twenty Twenty Eight | Minimum
Debt Instrument [Line Items]
Springing maturity condition FCCR liquidity percentage			130%
Springing maturity condition 1 liquidity percentage			130%
Springing maturity condition 2 liquidity percentage			130%
Secured Notes Due Twenty Twenty Eight | Maximum
Debt Instrument [Line Items]
Springing maturity condition FCCR - aggregate principal of FCCR convertible notes outstanding			$ 100,000,000
Springing maturity condition 1- aggregate principal of 2025 convertible notes outstanding			100,000,000
Springing maturity condition 2- aggregate principal of 2027 convertible notes outstanding			$ 100,000,000
Secured Term Loan Due Twenty Twenty Five
Debt Instrument [Line Items]
Debt Instrument, Face Amount		$ 205,000,000									$ 205,000,000
Total Interest Paid									5,100,000
Interest expense								$ 0	3,781,000
Interest paid included in Payoff Amount		1,100,000							1,100,000
Prepayment of Debt		161,000,000
Payment to extinguishment of debt		159,900,000
Extinguishment of third party fees		100,000
Repayment of debt		$ 204,700,000
Gain on extinguishment of debt									44,700,000
Other Long-Term Secured Debt
Debt Instrument [Line Items]
Outstanding Principal Balance				$ 10,200,000				10,200,000		10,300,000
Debt Instrument, Face Amount					$ 11,100,000
Interest rate, fixed percentage					5.20%
Debt instrument, maturity year month					2027-06
Net carrying value				10,000,000				10,000,000		10,200,000
Current portion of long-term debt, net				$ 500,000				500,000		$ 500,000
Convertible Senior Notes due 2025, 2027, 2030 and 2031
Debt Instrument [Line Items]
Debt instrument, convertible, settlement amount								$ 0	$ 0

Long-term Debt - Summary of Per

Long-term Debt - Summary of Periods that Each of the Convertible Notes Were Convertible at the Option of Holders (Details)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Convertible Senior Notes due 2025
Debt Instrument [Line Items]
Convertibility of convertible note	Convertible	Not convertible at any time
Convertible Senior Notes due 2027
Debt Instrument [Line Items]
Convertibility of convertible note	Not convertible at any time	Not convertible at any time
Convertible Senior Notes due 2030
Debt Instrument [Line Items]
Convertibility of convertible note	Not convertible at any time	n/a
Convertible Senior Notes due 2031
Debt Instrument [Line Items]
Convertibility of convertible note	Not convertible at any time	n/a

Long-term Debt - Schedule of _2

Long-term Debt - Schedule of Net Carrying Amount of Liability Component (Detail) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Convertible Debt
Debt Instrument [Line Items]
Outstanding principal amount	$ 3,103,750	$ 1,700,000
Unamortized Issuance Costs	(46,120)	(18,763)
Net Carrying Value	3,057,630	1,681,237
March 31, 2024	5,988,083	1,988,521
Convertible Senior Notes due 2025 | Convertible Debt
Debt Instrument [Line Items]
Outstanding principal amount	650,000	650,000
Unamortized Issuance Costs	(5,302)	(6,069)
Net Carrying Value	644,698	643,931
March 31, 2024	2,847,274	1,074,713
Convertible Senior Notes due 2027 | Convertible Debt
Debt Instrument [Line Items]
Outstanding principal amount	1,050,000	1,050,000
Unamortized Issuance Costs	(11,684)	(12,694)
Net Carrying Value	1,038,316	1,037,306
March 31, 2024	1,437,616	913,808
Convertible Senior Notes due 2030 | Convertible Debt
Debt Instrument [Line Items]
Outstanding principal amount	800,000
Unamortized Issuance Costs	(17,752)
Net Carrying Value	782,248
March 31, 2024	1,064,727
Convertible Senior Notes due 2031 | Convertible Debt
Debt Instrument [Line Items]
Outstanding principal amount	603,750
Unamortized Issuance Costs	(11,382)
Net Carrying Value	592,368
March 31, 2024	638,466
Secured Notes Due Twenty Twenty Eight
Debt Instrument [Line Items]
Outstanding principal amount	500,000	500,000
Unamortized Issuance Costs	(8,378)	(8,807)
March 31, 2024	483,125	485,070
Net Carrying	$ 491,622	$ 491,193

Long-term Debt - Schedule of In

Long-term Debt - Schedule of Interest Expense Related to Notes (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Debt Instrument [Line Items]
Amortization of Issuance Costs	$ 2,557	$ 2,210
Convertible Debt
Debt Instrument [Line Items]
Contractual Interest Expense	1,729	1,219
Amortization of Issuance Costs	2,114	1,763
Total interest expense	3,843	2,982
Convertible Senior Notes due 2025 | Convertible Debt
Debt Instrument [Line Items]
Contractual Interest Expense	1,219	1,219
Amortization of Issuance Costs	767	757
Total interest expense	1,986	1,976
Convertible Senior Notes due 2027 | Convertible Debt
Debt Instrument [Line Items]
Contractual Interest Expense	0	0
Amortization of Issuance Costs	1,010	1,006
Total interest expense	1,010	1,006
Convertible Senior Notes due 2030 | Convertible Debt
Debt Instrument [Line Items]
Contractual Interest Expense	319	0
Amortization of Issuance Costs	248	0
Total interest expense	567	0
Convertible Senior Notes due 2031 | Convertible Debt
Debt Instrument [Line Items]
Contractual Interest Expense	191	0
Amortization of Issuance Costs	89	0
Total interest expense	280	0
Secured Notes Due Twenty Twenty Eight
Debt Instrument [Line Items]
Contractual Interest Expense	7,656	7,656
Amortization of Issuance Costs	429	401
Total interest expense	8,085	8,057
Secured Term Loan Due Twenty Twenty Five
Debt Instrument [Line Items]
Contractual Interest Expense	$ 0	3,781
Amortization of Issuance Costs		31
Total interest expense		$ 3,812

Long-term Debt - Schedule of Ma

Long-term Debt - Schedule of Maturities of Debt Instruments (Detail) $ in Thousands	Mar. 31, 2024 USD ($)
Debt Instrument [Line Items]
2025	$ 547
2026	1,150,577
2027	1,050,608
2028	8,477
2029	1,403,750
Thereafter	0
Total	3,613,959
Convertible Senior Notes due 2025
Debt Instrument [Line Items]
2025	0
2026	650,000
2027	0
2028	0
2029	0
Thereafter	0
Total	650,000
Convertible Senior Notes due 2027
Debt Instrument [Line Items]
2025	0
2026	0
2027	1,050,000
2028	0
2029	0
Thereafter	0
Total	1,050,000
Convertible Senior Notes due 2030
Debt Instrument [Line Items]
2025	0
2026	0
2027	0
2028	0
2029	800,000
Thereafter	0
Total	800,000
Convertible Senior Notes due 2031
Debt Instrument [Line Items]
2025	0
2026	0
2027	0
2028	0
2029	603,750
Thereafter	0
Total	603,750
Senior Secured Notes Due Twenty Twenty Eight
Debt Instrument [Line Items]
2025	0
2026	500,000
2027	0
2028	0
2029	0
Thereafter	0
Total	500,000
Other Long-Term Secured Debt
Debt Instrument [Line Items]
2025	547
2026	577
2027	608
2028	8,477
2029	0
Thereafter	0
Total	$ 10,209

Commitments and Contingencies -

Commitments and Contingencies - Additional Information (Detail) - USD ($) $ in Millions	Mar. 31, 2024	Aug. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Chairman of the Board of Directors and Executive Chairman's personal income taxes involved with civil complaint in the District of Columbia		$ 25
Loss contingency estimate minimum loss	$ 1.2

Treasury Stock - Additional Inf

Treasury Stock - Additional Information (Detail) - USD ($) shares in Thousands, $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Equity, Class of Treasury Stock [Line Items]
Treasury stock, shares	8,684	8,684
Treasury stock, cost	$ 782,104	$ 782,104

Income Taxes - Additional Infor

Income Taxes - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
Income Taxes [Line Items]
Effective tax rate from operations	75.20%	(5660.60%)
Benefit from income taxes	$ 160,769	$ 453,187
Pretax loss	213,887	$ (8,006)
Valuation allowance	400
Unrecognized tax benefits	8,200
Other Long-Term Liabilities
Income Taxes [Line Items]
Unrecognized tax benefits	6,900		$ 8,300
Deferred Tax Assets, Net
Income Taxes [Line Items]
Unrecognized tax benefits	1,300
Prepaid Expenses and Other Current Assets
Income Taxes [Line Items]
Income taxes receivable	$ 9,300		$ 15,300

Share-based Compensation - Addi

Share-based Compensation - Additional Information (Detail) - USD ($)	1 Months Ended	3 Months Ended
	May 31, 2023	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023	May 23, 2023
Stock Option Awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options outstanding, shares		703,000		1,294,000
Stock options vested		109,250
Aggregate fair value of stock option vested		$ 32,700,000
Weighted average grant date fair value of stock option awards		$ 1,114.42
Share-based compensation expense recognized		$ 9,800,000	$ 12,900,000
Unrecognized share-based compensation expense		$ 66,500,000
Unrecognized compensation expense expected to be recognized		2 years 1 month 6 days
Stock option awards granted		9,000	0
Share-settled Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Aggregate fair value of stock option vested		$ 3,200,000	$ 3,400,000
Share-based compensation expense recognized		$ 4,700,000	$ 3,400,000
Unrecognized compensation expense expected to be recognized		3 years 3 months 18 days
Restricted stock units outstanding		196,830		185,000
Share-settled restricted stock units vested		6,002	5,780
Number of shares withheld to satisfy tax obligations		1,889	1,963
Shares issued		4,113	3,817
Granted, weighted average grant date fair value (in dollars per share)		$ 1,451.66	$ 258.65
Unrecognized share-based compensation expense		$ 84,100,000
Stock units granted		30,000
Share-settled Performance Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Aggregate fair value of stock option vested		$ 0
Unrecognized compensation expense expected to be recognized		2 years 8 months 12 days
Restricted stock units outstanding		30,000		25,000
Unrecognized share-based compensation expense		$ 25,800,000
Stock units granted		6,000	0
Class A | Stock Option Awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options outstanding, shares		702,571
2013 Equity Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Equity compensation plan expiration period	2023-05
2013 Equity Plan | Other Stock Based Awards and Cash Settled RSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation expense recognized		$ 1,800,000	$ 700,000
Unrecognized compensation expense expected to be recognized		10 months 24 days
Unrecognized share-based compensation expense		$ 700,000
2023 Equity Plan | Share-settled Performance Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted average grant date fair value of stock option awards		$ 3,071.27
Share-based compensation expense recognized		$ 1,100,000
Restricted stock units outstanding		30,285
2023 Equity Plan | Class A
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation, stock authorized					1,932,703
Shares of class A common stock reserved and available for future issuance		231,007
2021 Employee Stock Purchase Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation expense recognized		$ 400,000	$ 600,000
Unrecognized compensation expense expected to be recognized		4 months 24 days
Unrecognized share-based compensation expense		$ 700,000
2021 Employee Stock Purchase Plan | Class A
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation, stock authorized		100,000
Shares of class A common stock reserved and available for future issuance		52,675
Common stock, shares issued		6,932

Summary of Stock Option Activit

Summary of Stock Option Activity (Detail) - Stock Option Awards - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Options outstanding, shares
Beginning Balance	1,294
Granted	9	0
Exercised	(583)
Forfeited/Expired	(17)
Ending Balance	703
Exercisable as of March 31, 2024	385
Expected to vest as of March 31, 2024	318
Total	703
Weighted Average Exercise Price Per Share
Beginning Balance	$ 286.78
Granted	1,599.29
Exercised	233.42
Forfeited/Expired	447.47
Ending Balance	343.31
Exercisable as of March 31, 2024	294.39
Expected to vest as of March 31, 2024	402.45
Total	$ 343.31
Aggregate Intrinsic Value
Exercised	$ 468,114
Exercisable as of March 31, 2024	542,263
Expected to vest as of March 31, 2024	414,114
Total	$ 956,377
Weighted Average Remaining Contractual Term (Years)
Exercisable as of March 31, 2024	4 years 9 months 18 days
Expected to vest as of March 31, 2024	8 years
Total	6 years 2 months 12 days

Schedule of Range of Exercise P

Schedule of Range of Exercise Prices per Share (Detail) - Stock Option Awards shares in Thousands	3 Months Ended
	Mar. 31, 2024 $ / shares shares
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Shares, Stock Options Outstanding | shares	703
Weighted Average Exercise Price Per Share, Stock Options Outstanding	$ 343.31
Weighted Average Remaining Contractual Term (Years), Stock Options Outstanding	6 years 2 months 12 days
121.43 - 200.00
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Range of Exercise Prices per Share, minimum	$ 121.43
Range of Exercise Prices per Share, maximum	$ 200
Shares, Stock Options Outstanding | shares	280
Weighted Average Exercise Price Per Share, Stock Options Outstanding	$ 144.01
Weighted Average Remaining Contractual Term (Years), Stock Options Outstanding	3 years 10 months 24 days
200.01 - 300.00
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Range of Exercise Prices per Share, minimum	$ 200.01
Range of Exercise Prices per Share, maximum	$ 300
Shares, Stock Options Outstanding | shares	108
Weighted Average Exercise Price Per Share, Stock Options Outstanding	$ 251.21
Weighted Average Remaining Contractual Term (Years), Stock Options Outstanding	8 years 7 months 6 days
300.01 - 400.00
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Range of Exercise Prices per Share, minimum	$ 300.01
Range of Exercise Prices per Share, maximum	$ 400
Shares, Stock Options Outstanding | shares	3
Weighted Average Exercise Price Per Share, Stock Options Outstanding	$ 301.63
Weighted Average Remaining Contractual Term (Years), Stock Options Outstanding	9 years 2 months 12 days
400.01 - 500.00
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Range of Exercise Prices per Share, minimum	$ 400.01
Range of Exercise Prices per Share, maximum	$ 500
Shares, Stock Options Outstanding | shares	180
Weighted Average Exercise Price Per Share, Stock Options Outstanding	$ 411.49
Weighted Average Remaining Contractual Term (Years), Stock Options Outstanding	7 years 9 months 18 days
600.01 - 691.23
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Range of Exercise Prices per Share, minimum	$ 600.01
Range of Exercise Prices per Share, maximum	$ 700
Shares, Stock Options Outstanding | shares	123
Weighted Average Exercise Price Per Share, Stock Options Outstanding	$ 691.23
Weighted Average Remaining Contractual Term (Years), Stock Options Outstanding	6 years 10 months 24 days
1,500.01 - 1,599.29
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Range of Exercise Prices per Share, minimum	$ 1,500.01
Range of Exercise Prices per Share, maximum	$ 1,599.29
Shares, Stock Options Outstanding | shares	9
Weighted Average Exercise Price Per Share, Stock Options Outstanding	$ 1,599.29
Weighted Average Remaining Contractual Term (Years), Stock Options Outstanding	10 years

Assumptions Used in Black-Schol

Assumptions Used in Black-Scholes Pricing Model (Detail)	3 Months Ended
	Mar. 31, 2024
Stock Option Awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term of award in years	6 years 3 months 18 days
Expected volatility	75.10%
Risk-free interest rate	4.20%
Expected dividend yield	0%
Share-settled Performance Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term of award in years	3 years
Expected volatility	92.70%
Risk-free interest rate	4.40%
Expected dividend yield	0%

Summary of Share-Settled Restri

Summary of Share-Settled Restricted Stock Unit Activity (Detail) - Share-settled Restricted Stock Units $ in Thousands	3 Months Ended
	Mar. 31, 2024 USD ($) shares
Number of Shares/Units
Beginning Balance	185,000
Granted	30,000
Vested	(6,000)
Forfeited	(12,000)
Ending Balance	196,830
Expected to vest as of March 31, 2024	197,000
Aggregate Intrinsic Value
Vested | $	$ 4,307
Expected to vest as of March 31, 2024 | $	$ 335,509

Share-based Compensation - Summ

Share-based Compensation - Summary of Share-Settled Performance Stock Unit (Detail) - Share-settled Performance Stock Units - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Beginning Balance	25
Granted	6	0
Vested	0
Forfeited	(1)
Ending Balance	30
Expected to vest as of March 31, 2024	30
Aggregate Intrinsic Value
Vested	$ 0
Expected to vest as of March 31, 2024	$ 103,245

Summary of Components of Tax Be

Summary of Components of Tax Benefit Related To Equity Plan (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Tax benefit related to:
Share-based compensation expense	$ (4,192)	$ (3,225)
Exercises of stock options and vesting of share-settled restricted stock units	(104,306)	(85)
Total tax benefit related to the Company's equity plans	$ (108,498)	$ (3,310)

Basic and Diluted (Loss) Earn_3

Basic and Diluted (Loss) Earnings per Share - Additional Information (Detail) - shares	3 Months Ended
	Mar. 31, 2024	Dec. 31, 2023
Class of Stock [Line Items]
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Class A
Class of Stock [Line Items]
Common stock, votes per share	one
Class B Convertible
Class of Stock [Line Items]
Common stock, votes per share	ten

Basic and Diluted (Loss) Earn_4

Basic and Diluted (Loss) Earnings per Share - Computation of Basic and Diluted (Loss) Earnings per Share (Detail) - USD ($) $ / shares in Units, $ in Thousands		3 Months Ended
		Mar. 31, 2024	Mar. 31, 2023
Class of Stock [Line Items]
Net (loss) income - Basic		$ (53,118)	$ 461,193
Net (loss) income - Diluted		$ (53,118)	$ 463,327
Total weighted average shares of common stock outstanding - Basic		17,194,000	11,834,000
Total weighted average shares of common stock outstanding - Diluted		17,194,000	14,575,000
(Loss) earnings per share:
Basic (loss) earnings per share	[1]	$ (3.09)	$ 38.97
Diluted (loss) earnings per share	[1]	$ (3.09)	$ 31.79
Employee Stock Option
Class of Stock [Line Items]
Total weighted average shares of common stock outstanding - Diluted		0	354,000
RSU
Class of Stock [Line Items]
Total weighted average shares of common stock outstanding - Diluted		0	21,000
Employee Stock Purchase Plan
Class of Stock [Line Items]
Total weighted average shares of common stock outstanding - Diluted		0	0
Performance stock units
Class of Stock [Line Items]
Total weighted average shares of common stock outstanding - Diluted		0	0
2025 Convertible Notes
Class of Stock [Line Items]
Interest expense on Convertible Notes, net of tax		$ 0	$ 1,414
Total weighted average shares of common stock outstanding - Diluted		0	1,633,000
2027 Convertible Notes
Class of Stock [Line Items]
Interest expense on Convertible Notes, net of tax		$ 0	$ 720
Total weighted average shares of common stock outstanding - Diluted		0	733,000
2030 Convertible Notes
Class of Stock [Line Items]
Interest expense on Convertible Notes, net of tax		$ 0	$ 0
Total weighted average shares of common stock outstanding - Diluted		0	0
2031 Convertible Notes
Class of Stock [Line Items]
Interest expense on Convertible Notes, net of tax		$ 0	$ 0
Total weighted average shares of common stock outstanding - Diluted		0	0
Class A
Class of Stock [Line Items]
Total weighted average shares of common stock outstanding - Basic		15,230,000	9,870,000
Class B
Class of Stock [Line Items]
Total weighted average shares of common stock outstanding - Basic		1,964,000	1,964,000
[1] Basic and fully diluted (loss) earnings per share for class A and class B common stock are the same.

Basic and Diluted (Loss) Earn_5

Basic and Diluted (Loss) Earnings per Share - Schedule of Weighted Average of Potential Class A Common Stock Excluded from Computation of (Loss) Earnings Per Share (Detail) - Class A - shares shares in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Class of Stock [Line Items]
Weighted shares of potential class A stock excluded from calculation of diluted (loss) earnings per share	3,829	756
2025 Convertible Notes
Class of Stock [Line Items]
Weighted shares of potential class A stock excluded from calculation of diluted (loss) earnings per share	1,633	0
2027 Convertible Notes
Class of Stock [Line Items]
Weighted shares of potential class A stock excluded from calculation of diluted (loss) earnings per share	733	0
2030 Convertible Notes
Class of Stock [Line Items]
Weighted shares of potential class A stock excluded from calculation of diluted (loss) earnings per share	141	0
2031 Convertible Notes
Class of Stock [Line Items]
Weighted shares of potential class A stock excluded from calculation of diluted (loss) earnings per share	40	0
Employee Stock Option
Class of Stock [Line Items]
Weighted shares of potential class A stock excluded from calculation of diluted (loss) earnings per share	1,048	711
RSU
Class of Stock [Line Items]
Weighted shares of potential class A stock excluded from calculation of diluted (loss) earnings per share	181	42
Performance stock units
Class of Stock [Line Items]
Weighted shares of potential class A stock excluded from calculation of diluted (loss) earnings per share	52	0
Employee stock purchase plan
Class of Stock [Line Items]
Weighted shares of potential class A stock excluded from calculation of diluted (loss) earnings per share	1	3

At-the-Market Equity Offering_2

At-the-Market Equity Offerings - Summary of Active At-the-Market Equity Offering (Detail) - USD ($)						3 Months Ended			4 Months Ended	8 Months Ended
	Nov. 30, 2023	Nov. 29, 2023	Aug. 01, 2023	May 01, 2023	Sep. 09, 2022	Mar. 31, 2024	Jul. 31, 2023	Mar. 31, 2023	Nov. 29, 2023	May 01, 2023	Dec. 31, 2023
At Market Equity Offerings [Line Items]
Shares sold under such sales agreement						195,162		1,348,855
Net proceeds received from shares sold under such sales agreement						$ 137,152		$ 338,962
Class A
At Market Equity Offerings [Line Items]
Cumulative shares sold under such sales agreement						24,367,000					23,588,000
November 2023 Sales Agreement
At Market Equity Offerings [Line Items]
Shares sold under such sales agreement						195,162
Net proceeds received from shares sold under such sales agreement						$ 137,152
Cumulative shares sold under such sales agreement						1,272,077
November 2023 Sales Agreement | Cowen and Company LLC, Canaccord Genuity LLC, and BTIG, LLC
At Market Equity Offerings [Line Items]
Net proceeds received from shares sold under such sales agreement						$ 747,025,000
November 2023 Sales Agreement | Cowen and Company LLC, Canaccord Genuity LLC, and BTIG, LLC | Class A
At Market Equity Offerings [Line Items]
Agreement effective date	Nov. 30, 2023
Sales agents	Cowen and Company, LLC, Canaccord Genuity LLC, and BTIG, LLC
Maximum aggregate offering price	$ 750,000,000
Maximum commissions payable to sales agents on gross proceeds from the sale of shares	2%
August 2023 Sales Agreement
At Market Equity Offerings [Line Items]
Cumulative shares sold under such sales agreement						1,592,950
August 2023 Sales Agreement | Cowen, Canaccord and Berenberg Capital Markets LLC
At Market Equity Offerings [Line Items]
Net proceeds received from shares sold under such sales agreement									$ 737,760,000
August 2023 Sales Agreement | Cowen, Canaccord and Berenberg Capital Markets LLC | Class A
At Market Equity Offerings [Line Items]
Agreement effective date			Aug. 01, 2023
Sales agents			Cowen and Company, LLC, Canaccord Genuity LLC, and Berenberg Capital Markets LLC
Maximum aggregate offering price			$ 750,000,000
Maximum commissions payable to sales agents on gross proceeds from the sale of shares			2%
Date terminated		Nov. 29, 2023
May 2023 Sales Agreement
At Market Equity Offerings [Line Items]
Cumulative shares sold under such sales agreement						1,079,170
May 2023 Sales Agreement | Cowen and Canaccord Genuity
At Market Equity Offerings [Line Items]
Net proceeds received from shares sold under such sales agreement							$ 333,494,000
May 2023 Sales Agreement | Cowen and Canaccord Genuity | Class A
At Market Equity Offerings [Line Items]
Agreement effective date				May 01, 2023
Sales agents				Cowen and Company, LLC and Canaccord Genuity LLC
Maximum aggregate offering price				$ 625,000,000
Maximum commissions payable to sales agents on gross proceeds from the sale of shares				2%
Date terminated			Aug. 01, 2023
2022 Sales Agreement
At Market Equity Offerings [Line Items]
Shares sold under such sales agreement								1,348,855
Net proceeds received from shares sold under such sales agreement								$ 338,962
Cumulative shares sold under such sales agreement						1,567,430
2022 Sales Agreement | Cowen and BTIG
At Market Equity Offerings [Line Items]
Net proceeds received from shares sold under such sales agreement										$ 385,181,000
2022 Sales Agreement | Cowen and BTIG | Class A
At Market Equity Offerings [Line Items]
Agreement effective date					Sep. 09, 2022
Sales agents					Cowen and Company, LLC and BTIG, LLC
Maximum aggregate offering price					$ 500,000,000
Maximum commissions payable to sales agents on gross proceeds from the sale of shares					2%
Date terminated				May 01, 2023

At-the-Market Equity Offering_3

At-the-Market Equity Offerings - Summary of Sales Activity of Sales Agreement for At-the-Market Equity Offering (Details) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
At Market Equity Offerings [Line Items]
Shares sold under such sales agreement	195,162	1,348,855
Net proceeds received from shares sold under such sales agreement	$ 137,152	$ 338,962
2022 Sales Agreement
At Market Equity Offerings [Line Items]
Shares sold under such sales agreement		1,348,855
Net proceeds received from shares sold under such sales agreement		$ 338,962
November 2023 Sales Agreement
At Market Equity Offerings [Line Items]
Shares sold under such sales agreement	195,162
Net proceeds received from shares sold under such sales agreement	$ 137,152

Segment Information - Additiona

Segment Information - Additional Information (Detail)	3 Months Ended
	Mar. 31, 2024 Country Segment Customer	Mar. 31, 2023 Customer Country	Dec. 31, 2023 Country
Segment Reporting Information
Number of operating segments | Segment	1
Geographic Concentration Risk
Segment Reporting Information
Number of Individual Country accounted for 10% or more of total revenues	0	0
Number of Individual country accounted for 10% or more of total consolidated assets	0		0
Customer Concentration Risk | Sales Revenue, Goods, Net
Segment Reporting Information
Number of Individual Customer accounted for 10% or more of total consolidated revenues | Customer	0	0

Segment Information - Breakout

Segment Information - Breakout of Operations of Software Segment and Corporate & Other Costs (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Segment Reporting Information [Line Items]
Total revenues	$ 115,246	$ 121,915
Total cost of revenues	30,015	27,941
Gross profit	85,231	93,974
Total operating expenses	288,933	114,281
Loss from operations	(203,702)	(20,307)
Operating Segments | Software Business
Segment Reporting Information [Line Items]
Total revenues	115,246	121,915
Total cost of revenues	30,015	27,941
Gross profit	85,231	93,974
Total operating expenses	96,123	94,487
Loss from operations	(10,892)	(513)
Corporate & Other
Segment Reporting Information [Line Items]
Total operating expenses	192,810	19,794
Loss from operations	$ (192,810)	$ (19,794)

Total Revenues, Gross Profit, (

Total Revenues, Gross Profit, (Loss) Income from Operations, and Long-Lived Assets, by Geographic Region (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
Revenues from External Customers and Long-Lived Assets
Total revenues	$ 115,246	$ 121,915
Gross profit	85,231	93,974
(Loss) income from operations	(203,702)	(20,307)
Long-lived assets	84,201		$ 86,284
U.S
Revenues from External Customers and Long-Lived Assets
Total revenues	64,379	69,677
Gross profit	46,061	54,189
(Loss) income from operations	(211,490)	(33,088)
Long-lived assets	74,061		75,004
EMEA
Revenues from External Customers and Long-Lived Assets
Total revenues	38,353	38,020
Gross profit	30,900	29,697
(Loss) income from operations	13,640	16,521
Long-lived assets	3,486		3,937
Other Regions
Revenues from External Customers and Long-Lived Assets
Total revenues	12,514	14,218
Gross profit	8,270	10,088
(Loss) income from operations	(5,852)	$ (3,740)
Long-lived assets	$ 6,654		$ 7,343

Related Party Transactions - Ad

Related Party Transactions - Additional Information (Detail) - Board of Directors & Executive Chairman			3 Months Ended
	Jun. 12, 2023 USD ($) Extended Term	Jun. 24, 2022 USD ($)	Mar. 31, 2024 USD ($)
Excess Agreement
Related Party Transaction [Line Items]
One time payment fee		$ 600,000
Related party transaction, description		The Company paid Mr. Saylor $600,000 for a one-year term under the Excess Agreement
Excess indemnity coverage payable		$ 10,000,000
Refund of pro rate portion of previous payment		489,863
Tail Agreement
Related Party Transaction [Line Items]
One time payment fee	$ 157,000	150,000
Coverage amount		40,000,000
Additional amount		$ 150,000	$ 150,000
Related party transaction, description		$150,000 for a 90-day term under the Tail Agreement
Extended term		90 days	90 days
2023 Tail Agreement
Related Party Transaction [Line Items]
Additional amount per one year term extension	$ 157,000
Extended term	1 year
Option to extend number of additional one-year period under agreement | Extended Term	4

Subsequent Events - Additional

Subsequent Events - Additional Information (Detail)	1 Months Ended	3 Months Ended
	Apr. 26, 2024 USD ($) Bitcoin	Jun. 30, 2024 USD ($)	Mar. 31, 2024 USD ($) Bitcoin	Mar. 31, 2023 USD ($) Bitcoin
Subsequent Event [Line Items]
Number of Bitcoins Purchased | Bitcoin			25,128	7,500
Purchase of bitcoins, value			$ 1,639,309,000	$ 179,275,000
Digital asset impairment losses			$ 191,633,000	$ 18,911,000
Subsequent Event
Subsequent Event [Line Items]
Number of Bitcoins Purchased | Bitcoin	122
Purchase of bitcoins, value	$ 7,800,000
Purchase price per bitcoins	$ 63,548
2028 Secured Term Loan | Collateral Pledged | Subsequent Event
Subsequent Event [Line Items]
Number of Bitcoins Purchased | Bitcoin	122
Scenario Forecast
Subsequent Event [Line Items]
Digital asset impairment losses		$ 24,900,000